<doc>
  <docmeta id="113s2141rs">
    <bill congress="113" type="s" number="2141" version="rs"/>
    <revision size="98607" annotations="0" status="complete" id="9" commit-time="2014-09-29T16:12:27Z" committer="mbohmer" doc="113s2141rs/9.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Reported-in-Senate" public-private="public">
  <metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 S2141 RS: Sunscreen Innovation Act</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. Senate</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-09-17</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code>
    <calendar>Calendar No. 568</calendar>
    <congress>113th CONGRESS</congress>
    <session>2d Session</session>
    <legis-num>S. 2141</legis-num>
    <current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
    <action>
      <action-date date="20140313">March 13, 2014</action-date>
      <action-desc>
        <sponsor name-id="S259">Mr. Reed</sponsor> (for himself, <cosponsor name-id="S305">Mr. Isakson</cosponsor>, <cosponsor name-id="S337">Mr. Coons</cosponsor>, <cosponsor name-id="S307">Mr. Brown</cosponsor>, <cosponsor name-id="S277">Mr. Carper</cosponsor>, <cosponsor name-id="S349">Mr. Portman</cosponsor>, <cosponsor name-id="S340">Ms. Ayotte</cosponsor>, <cosponsor name-id="S260">Mr. Roberts</cosponsor>, <cosponsor name-id="S339">Mr. Kirk</cosponsor>, <cosponsor name-id="S366">Ms. Warren</cosponsor>, <cosponsor name-id="S174">Mr. McConnell</cosponsor>, <cosponsor name-id="S258">Ms. Landrieu</cosponsor>, <cosponsor name-id="S348">Mr. Paul</cosponsor>, <cosponsor name-id="S365">Mr. Scott</cosponsor>, <cosponsor name-id="S270">Mr. Schumer</cosponsor>, <cosponsor name-id="S320">Mrs. Hagan</cosponsor>, <cosponsor name-id="S172">Mr. Harkin</cosponsor>, <cosponsor name-id="S289">Mr. Alexander</cosponsor>, <cosponsor name-id="S300">Mr. Burr</cosponsor>, and <cosponsor name-id="S370">Mr. Booker</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name added-display-style="italic" committee-id="SSHR00" deleted-display-style="strikethrough">Committee on Health, Education, Labor, and Pensions</committee-name>
      </action-desc>
    </action>
    <action stage="Reported-in-Senate">
      <action-date date="20140917" legis-day="20140916">September 17 (legislative day, September 16), 2014</action-date>
      <action-desc>Reported by <sponsor name-id="S172">Mr. Harkin</sponsor>, with an amendment</action-desc>
      <action-instruction>Strike out all after the enacting clause and insert the part printed in italic</action-instruction>
    </action>
    <legis-type>A BILL</legis-type>
    <official-title>To amend the Federal Food, Drug, and Cosmetic Act to provide an alternative process for
			 review of safety and effectiveness of nonprescription sunscreen active
			 ingredients and for other purposes. </official-title>
  </form>
  <legis-body>
    <section changed="deleted" committee-id="SSHR00" id="S1" reported-display-style="strikethrough" section-type="section-one">
      <enum>1.</enum>
      <header>Short
			 title</header>
      <text display-inline="no-display-inline">This Act may be cited as
			 the <quote>
          <short-title>Sunscreen Innovation
			 Act</short-title>
        </quote>.</text>
    </section>
    <section changed="deleted" committee-id="SSHR00" id="id2657d9a11c6d44dcafa545cc09b3192e" reported-display-style="strikethrough">
      <enum>2.</enum>
      <header>Regulation of
			 nonprescription sunscreen active ingredients</header>
      <text display-inline="no-display-inline">Subchapter A of chapter V (21 U.S.C. 351 et
			 seq.) is amended by adding at the end the following:</text>
      <quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="id5F583987F3AF41AFA88E640167C2B510" reported-display-style="strikethrough" style="OLC">
        <section id="id09E5D37489EC4D84A278A032DBA7F932">
          <enum>524B.</enum>
          <header>Procedures
				for classifying sunscreen active ingredients</header>
          <subsection commented="no" id="id32E4E2EFAED14A7AAC64B0F202539F26">
            <enum>(a)</enum>
            <header>In general</header>
            <text>The Secretary
				shall review and determine whether nonprescription sunscreen
			 conditions are
				generally recognized as safe and effective and shall ensure that
			 any such
			 conditions that
				are marketed in the United States are appropriately labeled.</text>
          </subsection>
          <subsection id="idA93947450E6F434F85AC2E1E23851A37">
            <enum>(b)</enum>
            <header>Definitions</header>
            <paragraph id="idbb0dd6f7fe0f4a6b87a99e3379f0c6fe">
              <enum>(1)</enum>
              <header>Active
				ingredient</header>
              <text>The term <term>active ingredient</term> means any
				component that is intended to furnish pharmacological activity or
			 other direct
				effect in the diagnosis, cure, mitigation, treatment, or prevention
			 of disease,
				or to affect the structure or function of the body of humans or
			 animals.
				The term includes components that may undergo chemical change in
			 the
				manufacture of a drug and may be present in a drug in a
			 modified form
				intended to furnish the specified activity or effect.</text>
            </paragraph>
            <paragraph id="id9629e772152d43fa9dc1276a8d726694">
              <enum>(2)</enum>
              <header>Sunscreen
				active ingredient</header>
              <text>The term <term>sunscreen active
				ingredient</term> means an active ingredient that absorbs, reflects, or
				scatters radiation in the ultraviolet range at wavelengths from 290
			 to 400
				nanometers.</text>
            </paragraph>
            <paragraph id="id8561239ab2cb45fd834a2a95f51d75d6">
              <enum>(3)</enum>
              <header>Sunscreen
				condition</header>
              <text>The term <term>sunscreen condition</term> means a sunscreen active ingredient (or a combination of sunscreen active ingredients), dosage
			 form, dosage strength, or route of administration, marketed for a specific
			 nonprescription use.</text>
            </paragraph>
          </subsection>
          <subsection commented="no" id="id008fa93ba90749c49b80c64ebbd3f0b1">
            <enum>(c)</enum>
            <header>Criteria for
				eligibility</header>
            <text>To be eligible for review under this section, a sunscreen condition shall—</text>
            <paragraph commented="no" id="id288B75FD386948B3A45199BC461DF7A8">
              <enum>(1)</enum>
              <text>not be included in the stayed sunscreen
			 monograph; and</text>
            </paragraph>
            <paragraph commented="no" id="id8EBF62253C81420A94AE9663F843E36E">
              <enum>(2)</enum>
              <text>have been marketed as a  nonprescription sunscreen condition in the United States or at least 1
			 other country, or marketed as a cosmetic or dietary supplement in 1 or
			 more counties other than the United States—</text>
              <subparagraph commented="no" id="idD57880AC2D144B8BAC3BD30085F11D4D">
                <enum>(A)</enum>
                <text>for a minimum of 5 continuous years; and</text>
              </subparagraph>
              <subparagraph commented="no" id="id475D4875468B4338920DFBFB07FD6EA0">
                <enum>(B)</enum>
                <text>in sufficient quantity, as determined by the Secretary based upon the information submitted under
			 subparagraphs (D) and (E) of subsection (d)(1) and, if
			 applicable, subsection (d)(2)(A)(ii).</text>
              </subparagraph>
            </paragraph>
          </subsection>
          <subsection id="id18e25fa5485441e5be10d04e180d4865">
            <enum>(d)</enum>
            <header>Application for eligibility</header>
            <paragraph id="idE1C65F76DFF84F479BC736A8EC056FD3">
              <enum>(1)</enum>
              <header>In
				general</header>
              <text>A sponsor of a nonprescription sunscreen condition
				described in subsection (c) desiring to market such condition in
			 the United
				States may submit an application to the Secretary, in such manner
			 and
				containing such information as required by the Secretary, including
			 the
				following:</text>
              <subparagraph id="idc5a86345742f479ca86d3619d29d5883">
                <enum>(A)</enum>
                <text>Basic information
				about the sunscreen condition (including a description of each
			 active
				ingredient, pharmacologic class, intended nonprescription use,
			 nonprescription
				strength and dosage form, route of administration, and directions
			 for
				use).</text>
              </subparagraph>
              <subparagraph id="idB3B88ED18E7E4087945530AF0E7FE45D">
                <enum>(B)</enum>
                <text>A detailed chemical description of the sunscreen active ingredient that includes a full description
			 of the drug substance, including its physical and chemical
			 characteristics, the method of synthesis (or isolation) and purification
			 of the drug substance, and any specifications and analytical methods
			 necessary to ensure the identity, strength, quality, and purity of the
			 drug substance, including reference to the current edition of the official
			 National Formulary, the United States Pharmacopeia, or foreign
			 compendiums, where applicable.</text>
              </subparagraph>
              <subparagraph id="idFDA28802F6CE48169B68729D97DE7788">
                <enum>(C)</enum>
                <text>A list of each
				country in which the sunscreen condition has been marketed.</text>
              </subparagraph>
              <subparagraph id="idE04D9F0B12114819949DE356BD1098CB">
                <enum>(D)</enum>
                <text>The cumulative
				total number of dosage units sold for each dosage form of the
			 sunscreen
				condition, including total weight of the active ingredient, package
			 size for
				each dosage form in which the condition is marketed as
			 nonprescription, and an
				estimate of the minimum number of potential consumer exposures to
			 the
				condition.</text>
              </subparagraph>
              <subparagraph id="idE6804C8AF2D844EBA4D2BBFED21EC261">
                <enum>(E)</enum>
                <text>The use pattern
				(according to the label) for each country in which the sunscreen
			 condition is
				marketed and any changes in use pattern that have occurred over
			 time.</text>
              </subparagraph>
              <subparagraph id="id8c39d2b897f8434682f6790f81c21685">
                <enum>(F)</enum>
                <text>A list of all
				countries in which the sunscreen condition has been withdrawn from
			 marketing or
				in which an application for nonprescription marketing approval has
			 been denied
				and an explanation for such withdrawal or application denial.</text>
              </subparagraph>
            </paragraph>
            <paragraph commented="no" id="iddbf8aaf6a9554fd7a4ff98ee7e7445bf">
              <enum>(2)</enum>
              <header>Sunscreen conditions that have not been marketed in the United States for 5 continuous years</header>
              <subparagraph commented="no" id="id7E9940EF6C484F1BB4D4A1686F6D521D">
                <enum>(A)</enum>
                <header>In general</header>
                <text>In the case of an application with respect to a nonprescription sunscreen condition that has not
			 been marketed in the United States for 5 continuous years, in addition to
			 the information required under paragraph
			 (1), the sponsor shall submit the following information for each
				country in which the sunscreen condition has been marketed:</text>
                <clause id="id7153F824D631477A91F95602857D8354">
                  <enum>(i)</enum>
                  <text>The manner in
				which the sunscreen condition has been marketed to consumers. If
			 the sunscreen
				condition is marketed to consumers as a nonprescription pharmacy
			 only
				condition, the Secretary may require supplemental information.</text>
                </clause>
                <clause commented="no" id="id199F176CAB4F4E0083A97C5465E7B271">
                  <enum>(ii)</enum>
                  <text>A description of the population demographics and the source from which this information has been
			 compiled, to ensure that the sunscreen condition's use can be reasonably
			 extrapolated to the population of the United States.</text>
                </clause>
                <clause id="id924AD15457324C939B9524673D958FB8">
                  <enum>(iii)</enum>
                  <text>A description of
				the country’s system for identifying adverse drug experiences,
			 especially those
				found in nonprescription marketing experience, including method of
			 collection
				if applicable.</text>
                </clause>
                <clause id="id7926B88CB2FF4722804A49861A3E1398">
                  <enum>(iv)</enum>
                  <text>A statement of how long the sunscreen condition has been marketed in each country and how long the
			 current product labeling has been in use, accompanied by a copy of the
			 current product labeling, including a translation into English of any
			 labeling that is not in English, and a statement of whether the current
			 product labeling has been authorized, accepted, or approved by a
			 regulatory body in
			 each country where the condition is marketed.</text>
                </clause>
                <clause id="idDD9CBBFA1BBF4EC9B20D46671242E4B8">
                  <enum>(v)</enum>
                  <text>A list of all
				countries where the sunscreen condition is marketed as a
			 prescription drug only
				and an explanation for such restriction.</text>
                </clause>
              </subparagraph>
              <subparagraph id="id1E7DBBAF279D443BA83EFA5BB855722A">
                <enum>(B)</enum>
                <header>Sunscreen conditions that have been marketed in more than 5 countries</header>
                <clause id="id2BD00871B62245DBA950594D3343E3D7">
                  <enum>(i)</enum>
                  <header>In general</header>
                  <text>In the case of a sunscreen condition that has been marketed as a nonprescription sunscreen in more
			 than 5 countries, with a
			 minimum of 5 continuous years of marketing in at least one such country,
			 the
			 sponsor—</text>
                  <subclause id="id25DF5101CF2F461A9D0B82EB70CFB34B">
                    <enum>(I)</enum>
                    <text>may submit information in accordance with clauses (i) through (iv) of
			 subparagraph (A) with respect to only 5 such countries, including—</text>
                    <item id="id882E69A83AB74FC99657581E1C87A390">
                      <enum>(aa)</enum>
                      <text>the country with a
			 minimum
			 of 5 continuous years of nonprescription marketing;</text>
                    </item>
                    <item id="id0464FAD816BC4E23BE7CB1157BB2BE1F">
                      <enum>(bb)</enum>
                      <text>the country with 
			 the longest duration of marketing; and</text>
                    </item>
                    <item id="id86F9A2F2BD05409F875AE30106BB0686">
                      <enum>(cc)</enum>
                      <text>the country with the most support
			 for marketing, such as a large volume of sales with cultural
			 diversity among users of the product; and</text>
                    </item>
                  </subclause>
                  <subclause id="id7E07931F6C504836B20908F657B3CAFB">
                    <enum>(II)</enum>
                    <text>shall explain the basis for the countries selected under subclause (I); and</text>
                  </subclause>
                  <subclause id="id1D20F7645EFC4EBCAA80AF0DD1A57F0B">
                    <enum>(III)</enum>
                    <text>shall provide information from more than 5
			 countries if such information is needed to support the application.</text>
                  </subclause>
                </clause>
                <clause id="idC3054B5C4A4744479F81962DA37A0DC5">
                  <enum>(ii)</enum>
                  <header>Requirement</header>
                  <text>If the sunscreen condition
			 meets the criteria under items (aa) through (cc) of clause (i)(I) in 1 or
			 more countries listed in section 802(b)(1)(A), at least 1 such country
			 shall be included among the 5 countries selected under such clause (i)(I).</text>
                </clause>
              </subparagraph>
            </paragraph>
            <paragraph commented="no" id="id835519D888CC4BD3868F1B5041AE175B">
              <enum>(3)</enum>
              <header>Pending
				applications</header>
              <text>The requirements of this subsection shall not apply
				to a sunscreen condition deemed eligible for review of safety and
			 effectiveness
				by publication of a notice of eligibility in the Federal Register
			 prior to the
				date of enactment of the <short-title>Sunscreen Innovation
				Act</short-title>. Applications for such sunscreen conditions shall be
				considered in accordance with subsection (g).</text>
            </paragraph>
          </subsection>
          <subsection commented="no" id="id8c792c63bc7d44a6ac81335da7d53470">
            <enum>(e)</enum>
            <header>Public
				availability</header>
            <text>If a condition is found eligible under subsection
				(d), the Secretary shall make the application publicly available,
			 with
				redactions for confidential commercial information or trade secret
			 information,
				and any other information exempt from disclosure pursuant to
			 section 1905 of
				title 18, United States Code, <external-xref legal-doc="usc" parsable-cite="usc/5/552">section 552(b)</external-xref> of title 5, United
			 States Code, or
				section 301(j) of this Act. Applications shall remain confidential
			 during the
				Secretary's consideration of eligibility.</text>
          </subsection>
          <subsection id="id4b2216a501564acca58dd5ca05ec1699">
            <enum>(f)</enum>
            <header>New sunscreen
				condition application</header>
            <paragraph id="id8623E80F7C2D4B6385D455FEAFD1C27A">
              <enum>(1)</enum>
              <header>Eligibility
				determination</header>
              <text>Not later than 60 days after the submission of an eligibility
				application under subsection (d), the Secretary shall determine if
			 the sunscreen
				condition is eligible for further review for safety and
			 effectiveness. In the
				case of a sunscreen condition determined to be eligible, the
			 Secretary shall
				publish a notice of eligibility in the Federal Register, and
			 provide interested persons an opportunity to submit published and
			 unpublished data related to the safety and effectiveness of the sunscreen
			 condition for its intended nonprescription uses, in accordance with
			 paragraph
			 (2). In the
				case of a sunscreen condition determined not eligible, the
			 Secretary shall
				issue a letter to the sponsor, which shall be made publicly
			 available.</text>
            </paragraph>
            <paragraph id="id69cdb37a1d0c4ea3ac8da22da3cd441a">
              <enum>(2)</enum>
              <header>Safety and
				effectiveness data submissions</header>
              <subparagraph id="id659349BE0F424806AD3D5D318DAD76A3">
                <enum>(A)</enum>
                <header>In
				general</header>
                <text>Within 60 days of the publication in the Federal Register
				of an application deemed eligible, as described in paragraph (1),
			 the sponsor
				and other interested parties shall submit safety and effectiveness
			 data to the
				Secretary for further review, as described in subparagraph (B).</text>
              </subparagraph>
              <subparagraph id="id7d5879909ed041cca05fc1653d5aa964">
                <enum>(B)</enum>
                <header>Required submissions regarding data</header>
                <text>Submissions under this
			 paragraph shall
				include the following:</text>
                <clause id="idF98A4640F19A47699CF6F15B71785E9E">
                  <enum>(i)</enum>
                  <header>Human safety data</header>
                  <subclause id="id2115070B46594576B5CC4F027D5B969A">
                    <enum>(I)</enum>
                    <header>Individual active components</header>
                    <text>With respect to individual active components, controlled studies, partially controlled or
			 uncontrolled studies,
			 documented case reports, pertinent marketing experiences that may
			 influence a determination as to the safety of each individual active
			 component, and pertinent medical and scientific literature.</text>
                  </subclause>
                  <subclause id="id15C06EBF47FB4D018BF0A6AF12F66642">
                    <enum>(II)</enum>
                    <header>Combinations of individual active components</header>
                    <text>With respect to combinations of the individual active components, controlled studies,
			 partially controlled or
			 uncontrolled studies, documented case reports, pertinent marketing
			 experiences that may influence a determination as to the safety of
			 combinations of the individual active component, and pertinent medical and
			 scientific literature.</text>
                  </subclause>
                </clause>
                <clause id="idF1EDE7393E72430BB5E0FA5EFA78D245">
                  <enum>(ii)</enum>
                  <header>Efficacy data</header>
                  <subclause id="idF6A6E648531D45F3ABFE3C6D47ABEBE4">
                    <enum>(I)</enum>
                    <header>Individual active components</header>
                    <text>With respect to individual active components, controlled studies, partially controlled or
			 uncontrolled
			 studies, documented case reports, pertinent marketing experiences that may
			 influence a determination on the efficacy of each individual active
			 component, pertinent medical and scientific literature.</text>
                  </subclause>
                  <subclause id="id9FB4AE5DDA3543E6AE5D73B220824838">
                    <enum>(II)</enum>
                    <header>Combinations of individual active components</header>
                    <text>With respect to combinations of the individual active components, controlled studies,
			 partially controlled or
			 uncontrolled studies, documented case reports, pertinent marketing
			 experiences that may influence a determination on the efficacy of
			 combinations of the individual active components, and pertinent medical
			 and scientific literature.</text>
                  </subclause>
                </clause>
                <clause id="idCB855D0C079241D89F236C1861C37B86">
                  <enum>(iii)</enum>
                  <header>Data setting forth medical rationale and purpose</header>
                  <text>A summary of the data and views setting forth the medical rationale and purpose (or lack thereof)
			 for the sunscreen condition and the scientific basis (or lack thereof) for
			 the conclusion that the condition has been proven safe and effective for
			 the intended use. If there is an absence of controlled studies in the
			 material submitted, an explanation as to why such studies are not
			 considered necessary must be included.</text>
                </clause>
                <clause id="id5698C72B269C4B028749E826EC33D0A7">
                  <enum>(iv)</enum>
                  <header>Official drug monograph</header>
                  <text>An applicable United States Pharmacopoeia or National Formulary for the
			 sunscreen active ingredient or a proposed standard for inclusion in an
			 article to be recognized in an official drug monograph for the
			 active ingredient, including information showing that the official or
			 proposed compendial monograph for the active ingredient is consistent with
			 the active ingredient used in the studies establishing safety and
			 effectiveness and with the active ingredient marketed in the
			 nonprescription product to a material extent and for a material time.
			 If differences exist between the official or proposed compendial
			 monograph for the active ingredient and the active ingredient that is the
			 subject of the application, sponsor shall explain such differences.</text>
                </clause>
                <clause id="idBF48A72D26B8448A9D650A19F7F97A95">
                  <enum>(v)</enum>
                  <header>Adverse drug experiences</header>
                  <text>A list of all serious adverse drug experiences, as defined by the Secretary, from each country
			 where the
			 condition has been or is currently marketed as a prescription drug or as a
			 nonprescription drug or product.</text>
                </clause>
              </subparagraph>
              <subparagraph id="id8FC6E1BCF91A4C709A92BBED9A21BC42">
                <enum>(C)</enum>
                <header>Optional animal safety data</header>
                <text>In addition to the information required under subparagraph (B),  the sponsor may submit information
			 with respect to animal safety data, including controlled
			 studies and partially controlled or uncontrolled
			 studies, in the case of an application for individual active components,
			 and controlled
			 studies and partially controlled
			 or uncontrolled studies in the case of an application for combinations of
			 individual active components.</text>
              </subparagraph>
              <subparagraph commented="no" id="id996d652280954e01ab7879f683fdc713">
                <enum>(D)</enum>
                <header>Confidentiality
				of submissions</header>
                <text>The Secretary shall make data and information
				submitted by the sponsor, or pursuant to a notice requesting safety
			 and
				effectiveness data published in the Federal Register, publicly
			 available, with
				redactions for confidential commercial information or trade secret
			 information,
				and any other information exempt from disclosure pursuant to
			 section 1905 of
				title 18, United States Code, <external-xref legal-doc="usc" parsable-cite="usc/5/552">section 552(b)</external-xref> of title 5, United
			 States Code, or
				section 301(j) of this Act.</text>
              </subparagraph>
            </paragraph>
            <paragraph id="idd2ac2ac6232a4248a1728e624d45e4be">
              <enum>(3)</enum>
              <header>New sunscreen
				condition application submission to the advisory committee</header>
              <text>Not
				later than 30 days after the end of the public comment period
			 described in
				paragraph (2), the Secretary shall submit the application and the
			 safety and
				effectiveness data submitted under paragraph (2) to the
			 Nonprescription Drugs
				Advisory Committee (referred to in this section as the <quote>advisory
				committee</quote>) for review.</text>
            </paragraph>
          </subsection>
          <subsection id="id196a47accc41461e9c07ae9cb2c876fe">
            <enum>(g)</enum>
            <header>Pending
				sunscreen condition applications</header>
            <text>Not later than 30 days after the
				date of enactment of the <short-title>Sunscreen Innovation
				Act</short-title>, the Secretary shall submit to the advisory committee all safety and effectiveness data submitted
			 with respect to each
				application for review of sunscreen conditions that the Secretary
			 had
				determined, prior to the date of enactment of the
				<short-title>Sunscreen Innovation Act</short-title>, to be
				eligible for review of safety and effectiveness and for which the
			 information
				required under subsection (f)(2) has been submitted to the
			 Secretary prior to
				such date of enactment.</text>
          </subsection>
          <subsection id="id113CBC59342646BC8B0BC3D20EA8968E">
            <enum>(h)</enum>
            <header>Review and
				recommendation for nonprescription sunscreen condition</header>
            <paragraph id="idB732E3D9AF8E448F8D3CC56EE5388CED">
              <enum>(1)</enum>
              <header>In
				general</header>
              <text>The Secretary shall require the advisory committee to
				evaluate the safety and effectiveness data submitted in accordance
			 with
				subsection (f)(2) or (g).</text>
            </paragraph>
            <paragraph id="id5B017840DE014C61B820B3DB25A3337A">
              <enum>(2)</enum>
              <header>Standards</header>
              <text>In
				evaluating a nonprescription sunscreen condition under paragraph
			 (1), the
				advisory committee shall use the regulations in effect at the time
			 of the
				application, including regulations with respect to—</text>
              <subparagraph id="idF8DCEA34B759446EBD914CC6F34EC708">
                <enum>(A)</enum>
                <text>the safety of the
				nonprescription sunscreen condition;</text>
              </subparagraph>
              <subparagraph id="idF812C4339BE54A6297286BA928F8A1F0">
                <enum>(B)</enum>
                <text>the effectiveness
				of the nonprescription sunscreen condition;</text>
              </subparagraph>
              <subparagraph id="idA60006EEA1AB4818B5037652848165B1">
                <enum>(C)</enum>
                <text>the
				benefit-to-risk ratio of the nonprescription sunscreen condition;
			 and</text>
              </subparagraph>
              <subparagraph id="id8D3CB731E25846BDAEFC4122B9A5521E">
                <enum>(D)</enum>
                <text>the labeling of
				the nonprescription sunscreen condition.</text>
              </subparagraph>
            </paragraph>
            <paragraph id="idBBE44FC14BB1427A993EC669DD640F0A">
              <enum>(3)</enum>
              <header>Communications
				between advisory committee and other individuals who submit data</header>
              <text>The advisory committee
				shall have the authority to communicate with the sponsor and other
			 individuals who submit data during the
			 advisory
				committee's review, including requesting clarification or
			 additional
				information.</text>
            </paragraph>
            <paragraph id="id56E48445242D4AF7A28F54DF4BBBC12A">
              <enum>(4)</enum>
              <header>Recommendations</header>
              <subparagraph id="idF05AAC231780454F88429340C188D6E4">
                <enum>(A)</enum>
                <header>In
				general</header>
                <text>For each such submission under subsection (f)(3) or (g),
				the advisory committee shall make one of the following
			 recommendations to the
				Secretary:</text>
                <clause id="idb7a18bcbf7874495bf31066414a75240">
                  <enum>(i)</enum>
                  <text>The sunscreen
				condition is generally recognized as safe and effective (including
			 any or all
				indications), including nonprescription sunscreen conditions for
			 which a new
				drug application has been approved by the Secretary.</text>
                </clause>
                <clause id="id7f22e8b5e10244f7b8b66392cf74afa3">
                  <enum>(ii)</enum>
                  <text>Insufficient
				information has been provided to support a
			 recommendation that
				the sunscreen condition is generally recognized as safe and
			 effective
				(including any or all indications).</text>
                </clause>
                <clause id="idad086b07ae32464d9d453a5fd52ed841">
                  <enum>(iii)</enum>
                  <text>The sunscreen
				condition is not generally recognized as safe and effective to be
			 marketed or sold, unless an
				application with respect to such condition is approved under
			 section
				505(b).</text>
                </clause>
              </subparagraph>
              <subparagraph commented="no" id="id8a1c3b1b6ac04c5cb1c50701b20c7efa">
                <enum>(B)</enum>
                <header>Timing</header>
                <text>The
				advisory committee shall make a recommendation under subparagraph
			 (A) not later
				than 180 days after the advisory committee receives the application
			 and data
				submitted under subsection (f)(3) or subsection (g).</text>
              </subparagraph>
              <subparagraph commented="no" id="id3f9c00e70c6d40d58460ffedc1b1b510">
                <enum>(C)</enum>
                <header>Resubmission of
				data</header>
                <text>If the advisory committee recommends that insufficient
				information has been provided, in accordance with subparagraph
			 (A)(ii), the
				advisory committee shall make such recommendation not later than
			 180 days after
				the date on which such additional information is submitted.</text>
              </subparagraph>
            </paragraph>
          </subsection>
          <subsection id="idAF0EF215EF2C4C709C82DE57F4ED852A">
            <enum>(i)</enum>
            <header>Determination
				by the Center for Drug Evaluation and Research</header>
            <paragraph id="id9691662fef1a478b8791cceb94bda2b6">
              <enum>(1)</enum>
              <header>In
				general</header>
              <text>The Center for Drug Evaluation and Research shall respond
				to the recommendations of the advisory committee under subsection
			 (h)(4) as
				follows:</text>
              <subparagraph id="iddc61ea94ccd64b5e9867ec3152b3bf2c">
                <enum>(A)</enum>
                <text>In the case of a
				recommendation by the advisory committee described in clause (i) of
				subsection (h)(4), not later than 45 days after the advisory
			 committee issues
				the recommendation, the Center for Drug Evaluation and Research
			 shall issue a
				determination affirming or denying the recommendation of the
			 advisory
				committee. If the Center for Drug Evaluation and Research affirms
			 the
				recommendation of the advisory committee, or if the Center for Drug
			 Evaluation
				and Research takes no action regarding the recommendation within 45
			 days of
				receiving such recommendation, the nonprescription sunscreen
			 condition shall be
				generally recognized as safe and effective, not misbranded, and
			 permitted to be
				marketed and sold in accordance with all applicable rules and
			 regulations for
				over-the-counter drugs.</text>
              </subparagraph>
              <subparagraph id="id7f42b8df85554204bec490178e3ea21f">
                <enum>(B)</enum>
                <text>In the case of a
				recommendation described in clause (ii) of such subsection, the
			 Center for Drug
				Evaluation and Research shall issue a determination affirming or
			 denying the recommendation of the advisory committee, to be made publicly
			 available,
				within 45 days of receiving the recommendation, and inform the
			 sponsor that the sponsor must submit additional
			 information to the advisory committee in order to continue the
				review by the advisory committee.</text>
              </subparagraph>
              <subparagraph id="idae4ce6d59928428992d6685027a210d2">
                <enum>(C)</enum>
                <text>In the case of a
				recommendation described in clause (iii) of such subsection, the
			 Center for
				Drug Evaluation and Research shall issue a determination affirming
			 or denying the recommendation of the advisory committee, to be made
			 publicly
				available, within 45 days of receiving such recommendation,
			 and indicate whether
				such sunscreen condition determined to be not generally recognized
			 as safe and
			 effective to
				be marketed and sold, unless an application with respect to such
				condition is approved under section 505(b), or whether additional
			 data must be submitted to the advisory committee.</text>
              </subparagraph>
            </paragraph>
            <paragraph id="id597C0054D6E04C51A039F6715AC8D812">
              <enum>(2)</enum>
              <header>Supervisory
				review of determination</header>
              <subparagraph id="idCE29932071AA47C096FBE3B87A225110">
                <enum>(A)</enum>
                <header>In
				general</header>
                <text>Any person may request a supervisory review of a
				determination of the Center for Drug Evaluation and Research to not
			 accept a recommendation of an advisory committee. Such review may be
			 conducted at the next
			 supervisory
				or higher level above the individual who made the determination.</text>
              </subparagraph>
              <subparagraph id="id78d8367837644f9db9ead57efe4e62e0">
                <enum>(B)</enum>
                <header>Request for
				supervisory review</header>
                <text>A request described in subparagraph (A) shall
				be made to the Secretary not later than 30 days after such decision
			 and shall
				indicate in the request whether such person seeks an in-person
			 meeting or a
				teleconference. The Secretary shall schedule an in-person or
			 teleconference
				review, if so requested, not later than 30 days after such request
			 is made. The
				Secretary shall issue a decision to the person requesting a review
			 under this
				paragraph not later than 45 days after the meeting.</text>
              </subparagraph>
              <subparagraph id="idaf69e62cfb6645c0b9a7e8ec07e5211e">
                <enum>(C)</enum>
                <header>Standard of
				supervisory review</header>
                <text>The Secretary shall be authorized to overturn
				a determination of the Center for Drug Evaluation and Research not
			 to accept a
				recommendation of the advisory committee if the
			 supervisory review
				results in a decision by the reviewer that the individual who made
			 the
				determination did not provide reasonable and sufficient substantive
			 support for
				the decision to disregard the advisory committee's
				recommendation.</text>
              </subparagraph>
              <subparagraph commented="no" id="idfd637d9fc85642f59ba067d16a52d514">
                <enum>(D)</enum>
                <header>Supervisory
				review decision</header>
                <text>If the Secretary overturns a determination by the
				Center for Drug Evaluation and Research not to accept a favorable
				recommendation of an advisory committee, the nonprescription
			 sunscreen
				condition shall be generally recognized as safe and effective, not
			 misbranded,
				and permitted to be marketed and sold in accordance with all
			 applicable rules
				and regulations for over-the-counter drugs.</text>
              </subparagraph>
              <subparagraph commented="no" id="id9A846FDE48AF41B4B70112B7C176FEAD">
                <enum>(E)</enum>
                <header>Final agency
				action</header>
                <text>A decision made through supervisory review shall
				constitute final agency action subject to judicial review.</text>
              </subparagraph>
            </paragraph>
          </subsection>
          <subsection id="id58CA10D2CB3B416F974CAFA3195761C2">
            <enum>(j)</enum>
            <header>Reports</header>
            <paragraph id="id4A5099986A7F4F5E881C93BA5A8D2FB3">
              <enum>(1)</enum>
              <header>In
				general</header>
              <text>Not later than 1 year after the date of enactment of the
				<short-title>Sunscreen Innovation Act</short-title>, on
				March 1, 2015, and every 2 years thereafter, the Secretary shall
			 issue a report
				to Congress describing actions taken under this section.</text>
            </paragraph>
            <paragraph id="id021FCE2407114618B8178007EA14F315">
              <enum>(2)</enum>
              <header>Contents</header>
              <text>The
				reports under paragraph (1) shall include—</text>
              <subparagraph id="id92A84768472B4088B110296ACA097D95">
                <enum>(A)</enum>
                <text>a review of the
				progress made in issuing in a timely manner decisions on the safety
			 and
				effectiveness for sunscreen conditions for applications pending as
			 of the date
				of enactment of the <short-title>Sunscreen Innovation
				Act</short-title>, including the number of pending applications—</text>
                <clause id="id0C47EFF713D84ED29765B07CA5BA395B">
                  <enum>(i)</enum>
                  <text>reviewed and the
				decision times for each application, measured from the date of
			 original
				eligibility application submission by the sponsor;</text>
                </clause>
                <clause id="id608C7859176C4E129ED073F7E032B16E">
                  <enum>(ii)</enum>
                  <text>resulting in a
				determination of generally recognized as safe and effective and not
				misbranded;</text>
                </clause>
                <clause id="idE11AF46967FC40A4A76E8F26D9DA6490">
                  <enum>(iii)</enum>
                  <text>resulting in a
				determination of not generally recognized as safe and effective and
			 not
				misbranded and the reasons for such determinations; and</text>
                </clause>
                <clause id="id7E61E490F2D64E518CBDF2A8D5EDE1B4">
                  <enum>(iv)</enum>
                  <text>for which a
				determination has not been made, an explanation for the delay, a
			 description of
				the current status of each such application, and the length of time
			 such
				applications have been pending, measured from the date of original
			 eligibility
				application submission by the sponsor;</text>
                </clause>
              </subparagraph>
              <subparagraph id="idFA27F71040FF44FB8576886B862A6D47">
                <enum>(B)</enum>
                <text>a review of the
				progress made in issuing in a timely manner a decision on safety
			 and
				effectiveness for sunscreen condition applications submitted after
			 the date of
				enactment of the <short-title>Sunscreen Innovation
				Act</short-title>, including the number of such applications—</text>
                <clause id="idC3A9A27BC19E4FE28316D081447EE68E">
                  <enum>(i)</enum>
                  <text>reviewed and the
				decision times for each application;</text>
                </clause>
                <clause id="idAC747645164848B9A09BAEC779C183A9">
                  <enum>(ii)</enum>
                  <text>resulting in a
				determination of generally recognized as safe and effective and not
			 misbranded;
				and</text>
                </clause>
                <clause id="idE4B16F304D18405D923AB993AC5F6CF8">
                  <enum>(iii)</enum>
                  <text>resulting in a
				determination of not generally recognized as safe and effective and
			 not
				misbranded and the reasons for such determinations;</text>
                </clause>
              </subparagraph>
              <subparagraph id="idCC91246580CF441389C09C0FE65DAAC3">
                <enum>(C)</enum>
                <text>a description of
				the staffing and resources relating to the costs associated with
			 the review and
				decisionmaking pertaining to applications;</text>
              </subparagraph>
              <subparagraph id="id4c31d2d3eb964d59b3c02b28c35baeb0">
                <enum>(D)</enum>
                <text>a review of the
				progress in meeting the deadlines with respect to processing
			 applications under
				this section;</text>
              </subparagraph>
              <subparagraph id="id4c0754c503a246e381709ed87ef6555b">
                <enum>(E)</enum>
                <text>to the extent the
				Secretary determines appropriate, recommendations for process
			 improvements in
				the handling of pending and new applications; and</text>
              </subparagraph>
              <subparagraph id="idDB4EDC065DDC49F7B0EEDCB527861522">
                <enum>(F)</enum>
                <text>recommendations
				for expanding the applicability of this section to nonprescription
			 active
				ingredients or conditions that are not related to the sunscreen
			 category of
				over-the-counter drugs.</text>
              </subparagraph>
            </paragraph>
            <paragraph id="id44340A0E006A4C63936298CB9C55AE51">
              <enum>(3)</enum>
              <header>Method</header>
              <text>The
				Secretary shall publish the reports required under this subsection
			 in the
				manner the Secretary determines to be the most effective for
			 efficiently
				disseminating the report, including publication of the report on
			 the Internet
				website of the Food and Drug Administration.</text>
            </paragraph>
          </subsection>
          <subsection id="idD9FB621EE1AA417599CC41A5CB5E0927">
            <enum>(k)</enum>
            <header>Rules of
				construction</header>
            <paragraph id="id93375E09D5CC42B6B0C661AAC4F26B07">
              <enum>(1)</enum>
              <header>Authority to
				withdraw or suspend</header>
              <text>Nothing in this section shall be construed to
				alter the Secretary's authority to withdraw or suspend from the
			 market
			 a drug that
				the Secretary determines to be unsafe or ineffective.</text>
            </paragraph>
            <paragraph id="idCAF8FD8BD7CB49C69C69735F478D4C56">
              <enum>(2)</enum>
              <header>Other
				conditions</header>
              <text>Nothing in the section shall affect the Secretary's
				authority to review nonprescription conditions other than sunscreen
				conditions.</text>
            </paragraph>
          </subsection>
        </section>
        <after-quoted-block>.</after-quoted-block>
      </quoted-block>
    </section>
    <section changed="deleted" committee-id="SSHR00" id="id9B8BABF0397C43BBBAA5979D7B0E6A04" reported-display-style="strikethrough">
      <enum>3.</enum>
      <header>Sunscreen
			 testing and labeling</header>
      <text display-inline="no-display-inline">Not later
			 than 180 days after the date of enactment of this Act, the Secretary shall
			 issue determinations with respect to—</text>
      <paragraph id="idCF236921E93F418481C0E0ED8BDCCF9A">
        <enum>(1)</enum>
        <text display-inline="yes-display-inline">the appropriate testing and labeling
			 requirements for sunscreens sold as an aerosol; and</text>
      </paragraph>
      <paragraph id="id914B7DEC59664ADB9EB94BCC5DAC6C35">
        <enum>(2)</enum>
        <text display-inline="yes-display-inline">whether sunscreen may contain a label
			 indicating a sun protection factor greater than 50.</text>
      </paragraph>
    </section>
  </legis-body>
  <legis-body display-enacting-clause="no-display-enacting-clause">
    <section changed="added" committee-id="SSHR00" id="idd14143ba-341d-41dd-b0d4-d5d8190e90d6" reported-display-style="italic" section-type="section-one">
      <enum>1.</enum>
      <header>Short
			 title</header>
      <text display-inline="no-display-inline">This Act may be cited as
			 the <quote>
          <short-title>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation
			 Act</cato:entity-ref>
          </short-title>
        </quote>.</text>
    </section>
    <section changed="added" committee-id="SSHR00" id="H483241B3E42F421486BFE640298E1C40" reported-display-style="italic">
      <enum>2.</enum>
      <header>Regulation of nonprescription sunscreen active ingredients</header>
      <subsection id="id5622852E98CD462DA978E72AD0142501">
        <enum>(a)</enum>
        <header>In general</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/ch:V">Chapter V of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/351">
            <cato:entity-ref entity-type="uscode" value="usc/21/351/etseq">21 U.S.C. 351 et seq.</cato:entity-ref>
          </external-xref>)</cato:entity> is amended by adding
			 at the end the following:</text>
        <quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="H5EA949C80CCA474F981A0EE672D1FB13" reported-display-style="italic" style="OLC">
          <subchapter id="HC4A31FF1B8B641C6B7A37775C0C12437">
            <enum>I</enum>
            <header>Nonprescription sunscreen and other active ingredients</header>
            <section id="H3E107C336EE74F71ABD49B127B4D86FE">
              <enum>586.</enum>
              <header>Definitions</header>
              <text display-inline="no-display-inline">In this subchapter—</text>
              <paragraph id="H550DF649A2154FFBB457C162C68A26D1">
                <enum>(1)</enum>
                <text>the term <term>Advisory Committee</term> means the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-parent-id="7524" value="Nonprescription Drug Advisory Committee" entity-type="federal-body">Nonprescription Drug Advisory Committee of the Food and Drug Administration</cato:entity-ref> or any
			 successor to such <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-parent-id="7524" value="Nonprescription Drug Advisory Committee" entity-type="federal-body">Committee</cato:entity-ref>;</text>
              </paragraph>
              <paragraph commented="no" id="HCF0925B3FEE24C17A6CA188856B5C709">
                <enum>(2)</enum>
                <text>the term <term>final sunscreen order</term> means an order published by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> in the Federal Register containing information stating
			 that a nonprescription sunscreen active
			 ingredient or
			 combination of nonprescription sunscreen active ingredients—</text>
                <subparagraph commented="no" id="id957E1A6236454BF4A2751752FAAF762C">
                  <enum>(A)</enum>
                  <text>is GRASE and is not misbranded if marketed in accordance with such order; or</text>
                </subparagraph>
                <subparagraph commented="no" id="id61CE29151F58496AA64F8FEF73504DBF">
                  <enum>(B)</enum>
                  <text>is not GRASE and is misbranded;</text>
                </subparagraph>
              </paragraph>
              <paragraph id="id617475F16AE24488926B41E455C6ED49">
                <enum>(3)</enum>
                <text>the term <term>GRASE</term> means generally recognized, among experts qualified by scientific training and experience to
			 evaluate the safety and effectiveness of drugs, as safe and effective for
			 use under the conditions prescribed, recommended, or suggested in the
			 labeling of a drug as described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/s:201/ss:p" entity-type="act">section 201(p)</cato:entity-ref>;</text>
              </paragraph>
              <paragraph id="HF22F6CD1C8D94B23A03532BB95097DAA">
                <enum>(4)</enum>
                <text display-inline="yes-display-inline">the term <term>GRASE determination</term> means, with respect to a nonprescription active ingredient or a combination of
			 nonprescription active ingredients, a determination of whether
			 such ingredient or combination of ingredients is GRASE;</text>
              </paragraph>
              <paragraph id="H1C3C4EBDED15402EA8BF0829AA96DBFE">
                <enum>(5)</enum>
                <text>the term <term>nonprescription</term> means not subject to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1">section 503(b)(1)</cato:entity-ref>;</text>
              </paragraph>
              <paragraph id="idA806E63A28FC40849794A3519A2DF83E">
                <enum>(6)</enum>
                <text display-inline="yes-display-inline">the term <term>pending request</term> means each request with respect to a nonprescription sunscreen active ingredient submitted under
			 section
			 330.14 of title 21, Code of
			 Federal Regulations (as in effect on the date of enactment of the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                  </short-title>) for consideration for
			 inclusion in the over-the-counter drug monograph system—</text>
                <subparagraph id="H38627D6348F54B8285936A982AE32B65">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">that was determined to be eligible for such review by publication of a notice of eligibility in the
			 Federal
			 Register prior to the date of enactment of such Act;
			 and</text>
                </subparagraph>
                <subparagraph id="HC36F2B92F0DB49CB91DD7255D1337B24">
                  <enum>(B)</enum>
                  <text>for which safety and effectiveness data have been submitted to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> prior to such date of
			 enactment;</text>
                </subparagraph>
              </paragraph>
              <paragraph commented="no" id="H3B008EA9F4C244919DF46E137367A35B">
                <enum>(7)</enum>
                <text display-inline="yes-display-inline">the term <term>proposed sunscreen order</term> means an order containing a tentative determination published by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> in the Federal
			 Register containing information proposing that a nonprescription sunscreen
			 active
			 ingredient or
			 combination of nonprescription sunscreen active ingredients—</text>
                <subparagraph commented="no" id="id54F6339176C74F8299AEC7DE079CC47E">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">is GRASE and is not misbranded if marketed in accordance with such order;</text>
                </subparagraph>
                <subparagraph commented="no" id="id02BBC807616048EF853C7740E87DC176">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">is not GRASE and is misbranded; or</text>
                </subparagraph>
                <subparagraph commented="no" id="id9257D9D88B524804A44063B2A5E3FB6D">
                  <enum>(C)</enum>
                  <text display-inline="yes-display-inline">is not GRASE and is misbranded because the data are
			 insufficient to classify such ingredient or
			 combination of ingredients as GRASE and not misbranded and additional
			 information is necessary to allow the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> to determine otherwise;</text>
                </subparagraph>
              </paragraph>
              <paragraph commented="no" id="HB249BECD3E2C42F3A83605803F3A9BD1">
                <enum>(8)</enum>
                <text display-inline="yes-display-inline">the term <term>sponsor</term> means the person that submitted—</text>
                <subparagraph commented="no" id="id69421A2FA70F406BB4122AB4083386BF">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">a request under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586A" entity-type="act">section 586A</cato:entity-ref>;</text>
                </subparagraph>
                <subparagraph commented="no" id="id8654E0C6EF9E4AAE8BAF160097614D78">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">a pending
			 request; or</text>
                </subparagraph>
                <subparagraph commented="no" id="idB3F209850C8C4EFB9771F5ED48E8D5BE">
                  <enum>(C)</enum>
                  <text>any other application subject to this subchapter;</text>
                </subparagraph>
              </paragraph>
              <paragraph commented="no" id="idF5F36369C90649EEB6ACB5CC77FC0655">
                <enum>(9)</enum>
                <text display-inline="yes-display-inline">the term <term>sunscreen</term> means a drug containing one or more sunscreen active ingredients; and</text>
              </paragraph>
              <paragraph id="HF48EC21968E340DE98F1433EE68287D7">
                <enum>(10)</enum>
                <text>the term <term>sunscreen active ingredient</term> means an active ingredient that is intended for application to the skin of humans for purposes of
			 absorbing, reflecting, or scattering ultraviolet radiation.</text>
              </paragraph>
            </section>
            <section id="H6B2BFB5809194E328557E0E772C1224A">
              <enum>586A.</enum>
              <header>Submission of requests</header>
              <text display-inline="no-display-inline">Any person may submit a request to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> for a determination of whether a
			 nonprescription
			 sunscreen active ingredient or a combination of nonprescription sunscreen
			 active ingredients, for use under specified conditions, to be prescribed,
			 recommended, or suggested in the labeling thereof
						(including dosage form,
			 dosage strength, and route of administration) is GRASE and should be
			 included in  part 352 of title 21, Code of Federal Regulations (or any
			 successor regulations) concerning nonprescription sunscreen.</text>
            </section>
            <section id="HA1A9980257D042E8AA7EF7F5D987AD62">
              <enum>586B.</enum>
              <header>Eligibility determinations; data submission; filing</header>
              <subsection id="H897EC71A9CA9459B959AE76B1F306DEA">
                <enum>(a)</enum>
                <header>Eligibility determinations</header>
                <paragraph id="idE549D5161AE7418C8049FE6E2487AE94">
                  <enum>(1)</enum>
                  <header>In general</header>
                  <text display-inline="yes-display-inline">Not later than 60 calendar days after the date of
			 receipt
			 of a request under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586A" entity-type="act">section 586A</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall—</text>
                  <subparagraph id="H5FF12FCFB6CA4793BE02D04E42D28E85">
                    <enum>(A)</enum>
                    <text>determine, in
			 accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:a/p:2" entity-type="act">paragraph (2)</cato:entity-ref>, whether the request is eligible for
			 further review under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b" entity-type="act">subsection (b)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C" entity-type="act">section 586C</cato:entity-ref>;</text>
                  </subparagraph>
                  <subparagraph id="H41DE0ADF3E6E49148C403BFE44CE1856">
                    <enum>(B)</enum>
                    <text>notify the sponsor of the determination of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref>; and</text>
                  </subparagraph>
                  <subparagraph id="HD1131959054F4884B312CE48A3ABABBB">
                    <enum>(C)</enum>
                    <text>make such determination publicly available in accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:a/p:3" entity-type="act">paragraph (3)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b/p:1" entity-type="act">subsection (b)(1)</cato:entity-ref>.</text>
                  </subparagraph>
                </paragraph>
                <paragraph id="H8D0A2BDBD53747E48751727F29F3CDCB">
                  <enum>(2)</enum>
                  <header>Criteria for eligibility</header>
                  <subparagraph id="HE9AADF803CDF4B7583628DCB0CBD0A95">
                    <enum>(A)</enum>
                    <header>In general</header>
                    <text>To be eligible for review under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b" entity-type="act">subsection (b)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C" entity-type="act">section 586C</cato:entity-ref>, a request shall be for a
			 nonprescription
			 sunscreen active ingredient or combination of nonprescription sunscreen
			 active ingredients, for use under specified conditions, to be prescribed,
			 recommended, or suggested in the labeling thereof, that—</text>
                    <clause id="HCA16AE8B8D9B41C7B146496AD512DA78">
                      <enum>(i)</enum>
                      <text>is not included in part 352 of title 21, Code of Federal
			 Regulations (or any successor regulations) concerning nonprescription
			 sunscreen; and</text>
                    </clause>
                    <clause id="HD3E9CA6053264038A891AA7C5EBA0CF0">
                      <enum>(ii)</enum>
                      <text>has been used to a material extent and for a material time under such conditions, as described in
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/s:201/ss:p/p:2" entity-type="act">section 201(p)(2)</cato:entity-ref>.</text>
                    </clause>
                  </subparagraph>
                  <subparagraph id="H6A99AA2413514F8B99D1649BAB6AA1BC">
                    <enum>(B)</enum>
                    <header>Establishment of time and extent</header>
                    <text>A sponsor shall include in a request under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586A" entity-type="act">section 586A</cato:entity-ref> the information required under section
			 330.14 of title 21, Code of Federal Regulations (or any successor
			 regulations) to meet the standard described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:a/p:2/sp:A/cl:ii" entity-type="act">subparagraph (A)(ii)</cato:entity-ref>.</text>
                  </subparagraph>
                </paragraph>
                <paragraph id="H95438D00084C49298B31DD1C03630F49">
                  <enum>(3)</enum>
                  <header>Public availability</header>
                  <subparagraph id="H30BF9DEFAA794D49A0D3E8B4960398BE">
                    <enum>(A)</enum>
                    <header>Redactions for confidential information</header>
                    <text display-inline="yes-display-inline">If a nonprescription sunscreen active ingredient or combination of nonprescription sunscreen active
			 ingredients is determined under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:a/p:1/sp:A" entity-type="act">paragraph (1)(A)</cato:entity-ref> to be eligible for further review, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall
			 make the request publicly
			 available, with redactions for information that is treated as confidential
			 under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="usc/5/552/b" entity-type="uscode">
                        <external-xref legal-doc="usc" parsable-cite="usc/5/552">section 552(b)</external-xref> of title 5, United States Code</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="usc/18/1905" entity-type="uscode">section 1905 of title
			 18, United States Code</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:301/ss:j">section 301(j) of this Act</cato:entity-ref>.</text>
                  </subparagraph>
                  <subparagraph id="H3DB5D6031CE84CF69040C9ECE8EA755A">
                    <enum>(B)</enum>
                    <header>Identification of confidential information by sponsor</header>
                    <text>At the time that a request is made under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586A" entity-type="act">section 586A</cato:entity-ref>, the sponsor of such request shall identify
			 any
			 information that such sponsor considers to be
			 confidential information
			 described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:a/p:3/sp:A" entity-type="act">subparagraph (A)</cato:entity-ref>.</text>
                  </subparagraph>
                  <subparagraph id="id7D172B819DD844B0BACCA6B08DF9799B">
                    <enum>(C)</enum>
                    <header>Confidentiality during eligibility review</header>
                    <text>The information contained in a request under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586A" entity-type="act">section 586A</cato:entity-ref> shall remain confidential during the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary’s</cato:entity-ref> consideration under this section of whether the request is
			 eligible for further review  consistent with <external-xref legal-doc="usc" parsable-cite="usc/21/330">section 330.14</external-xref> of title 21,
			 Code of Federal Regulations (or any successor regulations).</text>
                  </subparagraph>
                </paragraph>
              </subsection>
              <subsection id="H98B4CCAA85274E28B55607351CC5DB6B">
                <enum>(b)</enum>
                <header>Data submission and filing of requests</header>
                <paragraph id="HCEBC8FBAA8EE476EA5A28884F6FD5C17">
                  <enum>(1)</enum>
                  <header>In general</header>
                  <text display-inline="yes-display-inline">In the case of a request under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586A" entity-type="act">section 586A</cato:entity-ref> that is determined to be eligible under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:a" entity-type="act">subsection (a)</cato:entity-ref>
			 for further review under this section and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C" entity-type="act">section 586C</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref>
			 shall, in notifying the public under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:a/p:1/sp:C" entity-type="act">subsection (a)(1)(C)</cato:entity-ref> of such
			 eligibility
			 determination, post the eligibility determination on the Internet website
			 of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Food and Drug Administration</cato:entity-ref>, invite the sponsor of such request
			 and any other interested party to submit comments, and provide a period of
			 not less than
			 45
			 calendar days for comments in support of or otherwise relating to a GRASE
			 determination,
			 including published and unpublished data and other information related to
			 the safety and efficacy of such request.</text>
                </paragraph>
                <paragraph id="idD71C9BABA4E14530B2D98FCC8B1613DF">
                  <enum>(2)</enum>
                  <header>Filing determination</header>
                  <text>Not later than 60 calendar days after the submission of data and other information described in
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b/p:1" entity-type="act">paragraph (1)</cato:entity-ref> by the
			 sponsor, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall determine whether the data and other
			 information submitted by the sponsor under this section are sufficiently
			 complete, including being formatted in a manner that enables the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref>
			 to determine the completeness of such data and information, to enable the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> to conduct a substantive
			 review under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C" entity-type="act">section 586C</cato:entity-ref> with respect to such
			 request. Not later than 60 calendar days after the submission of data and
			 other information described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b/p:1" entity-type="act">paragraph (1)</cato:entity-ref> by the sponsor, if the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> determines—</text>
                  <subparagraph id="idbd5f9d323f594301b17ed26b5aa2ee73">
                    <enum>(A)</enum>
                    <text>that such data and other information are sufficiently complete, the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall—</text>
                    <clause id="H375534F49F02452B8A48D5A05CAEB16D">
                      <enum>(i)</enum>
                      <text display-inline="yes-display-inline">issue a written notification to the sponsor of the determination to file such
			 request, and make such notification publicly available; and</text>
                    </clause>
                    <clause id="HD92A8FBECF9244A2B1201E281E2F9EA5">
                      <enum>(ii)</enum>
                      <text>file such request made under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586A" entity-type="act">section 586A</cato:entity-ref>; or</text>
                    </clause>
                  </subparagraph>
                  <subparagraph id="ida95beb6e305149a4b1b3faae4dad11f5">
                    <enum>(B)</enum>
                    <text>that such data and other information are not sufficiently complete, the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall issue a written notification to the sponsor of the
			 determination to refuse to
			 file the request,  which shall include the reasons for the refusal,
			 including why such
			 data and other information are not sufficiently complete,  and make such
			 notification publicly available.</text>
                  </subparagraph>
                </paragraph>
                <paragraph id="idC007930E6FB948D9815E2B730E02752D">
                  <enum>(3)</enum>
                  <header>Refusal to file a request</header>
                  <subparagraph id="id643557E19EBE46DBB141DFBECA963558">
                    <enum>(A)</enum>
                    <header>Request for meetings; submission of additional data or other information</header>
                    <text>If the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> refuses to file a request made under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586A" entity-type="act">section 586A</cato:entity-ref>, the sponsor may—</text>
                    <clause id="H995F2F2660D84C2D83F6401BBC69BD29">
                      <enum>(i)</enum>
                      <text>within 30 calendar days of receipt of written notification of such refusal, request, in writing, a
			 meeting
			 with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> regarding the filing determination; and</text>
                    </clause>
                    <clause id="id1E8D36A78AB646FDB3F5899581DFDC74">
                      <enum>(ii)</enum>
                      <text>submit additional data or other information.</text>
                    </clause>
                  </subparagraph>
                  <subparagraph id="id4778BCCFA3D547DCA685FA1FDE853EE8">
                    <enum>(B)</enum>
                    <header>Meetings</header>
                    <clause id="id558BCC9B787E4FC6A838A82E40A37EA6">
                      <enum>(i)</enum>
                      <header>In general</header>
                      <text>If a sponsor seeks a meeting under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b/p:3/sp:A/cl:i" entity-type="act">subparagraph (A)(i)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall convene the meeting
			 within 30 calendar days of  the request for such meeting.</text>
                    </clause>
                    <clause id="idD53604D61F714D5B8C5537999DC85759">
                      <enum>(ii)</enum>
                      <header>Actions after meeting</header>
                      <text>Following any meeting held under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b/p:3/sp:B/cl:i" entity-type="act">clause (i)</cato:entity-ref>—</text>
                      <subclause id="H1F4FF37B8E1A411E99019226121E868B">
                        <enum>(I)</enum>
                        <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> may file the request within 60 calendar days;</text>
                      </subclause>
                      <subclause id="id8BAF8D4D99CC403ABBDB222A319025E2">
                        <enum>(II)</enum>
                        <text>the sponsor may submit additional data or other information; or</text>
                      </subclause>
                      <subclause id="id22A14F05537045D49CD42FA46BC067A5">
                        <enum>(III)</enum>
                        <text>if the sponsor elects, within 120 calendar days, to have the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> file the request (with or
			 without
			 amendments to correct
			 any
			 purported deficiencies to the request)—</text>
                        <item id="id49AC81A5AD454F53B4F272D7562DC12D">
                          <enum>(aa)</enum>
                          <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall file the
			 request over protest, not later than 30 calendar days after
			 the sponsor makes such election;</text>
                        </item>
                        <item id="id4D4C137EED89474F961E13BB38D6F03F">
                          <enum>(bb)</enum>
                          <text>at the time of filing, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall provide written notification of such filing to the
			 sponsor; and</text>
                        </item>
                        <item id="idB385F75D816D42D3BFA5E95845B5CE0A">
                          <enum>(cc)</enum>
                          <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall make such notification publicly available.</text>
                        </item>
                      </subclause>
                    </clause>
                    <clause id="id3E8D270AD2A54D919647CDDD20BC5111">
                      <enum>(iii)</enum>
                      <header>Requests filed over protest</header>
                      <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall not require the sponsor to resubmit a
			 copy of the request for purposes of filing a request filed over protest,
			 as described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b/p:3/sp:B/cl:ii/scl:III" entity-type="act">clause (ii)(III)</cato:entity-ref>.</text>
                    </clause>
                  </subparagraph>
                  <subparagraph id="HECA32D872ACF43089B8E1368C65F2E18">
                    <enum>(C)</enum>
                    <header>Submissions of additional data or other information</header>
                    <text>Within 60 calendar days of any submission of additional data or other information under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b/p:3/sp:A/cl:ii" entity-type="act">subparagraph (A)(ii)</cato:entity-ref> or
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b/p:3/sp:B/cl:ii/scl:II" entity-type="act">(B)(ii)(II)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall reconsider the previous determination
			 made under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b/p:2" entity-type="act">paragraph (2)</cato:entity-ref> with respect to the applicable request and make a
			 new determination in accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b/p:2" entity-type="act">paragraph (2)</cato:entity-ref>.</text>
                  </subparagraph>
                </paragraph>
                <paragraph id="H65FDCE94C1B44C3081A55D0E7B4785D6">
                  <enum>(4)</enum>
                  <header>Public availability</header>
                  <subparagraph id="H3A5D0584557642659E037145A30878D1">
                    <enum>(A)</enum>
                    <header>Redactions for confidential information</header>
                    <text display-inline="yes-display-inline">After the period of confidentiality described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:a/p:3/sp:C" entity-type="act">subsection (a)(3)(C)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall make
			 data and other information submitted in connection with a request under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586A" entity-type="act">section 586A</cato:entity-ref> publicly available, with redactions for information that
			 is treated as confidential under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="usc/5/552/b" entity-type="uscode">
                        <external-xref legal-doc="usc" parsable-cite="usc/5/552">section 552(b)</external-xref> of title 5, United States
			 Code</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="usc/18/1905" entity-type="uscode">
                        <external-xref legal-doc="usc" parsable-cite="usc/18/1905">section 1905</external-xref> of title 18, United States Code</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:301/ss:j">section 301(j) of
			 this Act</cato:entity-ref>.</text>
                  </subparagraph>
                  <subparagraph id="H419F4027466E4EB199B90E215D89EFB7">
                    <enum>(B)</enum>
                    <header>Identification of confidential information by sponsor</header>
                    <text>A person submitting information under this section shall identify at the time of such submission
			 the portions
			 of such information that the person  considers to be
			 confidential information described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b/p:4/sp:A" entity-type="act">subparagraph (A)</cato:entity-ref>.</text>
                  </subparagraph>
                </paragraph>
              </subsection>
            </section>
            <section id="HA6F0BE086CE846BFA0FF474BD557E768">
              <enum>586C.</enum>
              <header>GRASE determination</header>
              <subsection id="H8590F5CF76484BD39A7D14E6077A2DBA">
                <enum>(a)</enum>
                <header>Review of new request</header>
                <paragraph id="H8594D5EA3AC5425FB06BE00C166141AA">
                  <enum>(1)</enum>
                  <header>Proposed sunscreen order</header>
                  <text>In the case of a request under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586A" entity-type="act">section 586A</cato:entity-ref>, not later than 300 calendar days after the date on
			 which such request is filed under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b/p:2/sp:A" entity-type="act">subsection (b)(2)(A)</cato:entity-ref> or
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b/p:3/sp:B/cl:ii/scl:III" entity-type="act">(b)(3)(B)(ii)(III)
			 of section 586B</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref>—</text>
                  <subparagraph id="id44CD4BD674F34B4296A336C64324F5B2">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">may convene a meeting of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-parent-id="7524" value="Nonprescription Drug Advisory Committee" entity-type="federal-body">Advisory Committee</cato:entity-ref> to review such request; and</text>
                  </subparagraph>
                  <subparagraph id="idC60350A9BFD046D0B691B7264E09CEA9">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">shall complete the review of such request and issue a proposed sunscreen order with respect to such
			 request.</text>
                  </subparagraph>
                </paragraph>
                <paragraph id="HC76A4BC7DD1643D59D901737BA702F6A">
                  <enum>(2)</enum>
                  <header>Proposed sunscreen order by Commissioner</header>
                  <text display-inline="yes-display-inline">If the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> does not issue a proposed sunscreen order under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:a/p:1/sp:B" entity-type="act">paragraph (1)(B)</cato:entity-ref> within such
			 300-day period,
			 the sponsor of such  request may notify the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Office of the Commissioner" entity-parent-id="7524">Office of the Commissioner</cato:entity-ref> of
			 such request and request review by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Office of the Commissioner" entity-parent-id="7524">Office of the Commissioner</cato:entity-ref>.
			 If such sponsor so notifies the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Office of the Commissioner" entity-parent-id="7524">Office of the
			 Commissioner</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Commissioner</cato:entity-ref> shall, not later than 60
			 calendar days after the date of
			 notification under this paragraph, issue a proposed sunscreen order with
			 respect to such
			 request.</text>
                </paragraph>
                <paragraph commented="no" id="HD44C1F252F9848E2A4C89FCF98FE876A">
                  <enum>(3)</enum>
                  <header>Public comment period</header>
                  <text>A proposed sunscreen order issued under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:a/p:1/sp:B" entity-type="act">paragraph (1)(B)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:a/p:2" entity-type="act">(2)</cato:entity-ref> with respect to a request shall
			 provide for a period of 45 calendar days for public comment.</text>
                </paragraph>
                <paragraph id="HBBC0090F884A40D28B39634DDC5B6C4D">
                  <enum>(4)</enum>
                  <header>Meeting</header>
                  <text>A sponsor may request, in writing, a meeting with respect to a proposed sunscreen order issued
			 under this subsection and described in
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586/p:7/sp:B" entity-type="act">subparagraph (B)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586/p:7/sp:C" entity-type="act">(C) of section 586(7)</cato:entity-ref>, not later than 30 calendar
			 days after the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> issues such order.  The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall convene a
			 meeting with such sponsor not later than 45 calendar days after such
			 request for a meeting.</text>
                </paragraph>
                <paragraph id="id399E61FE37CD438F881017514F664F9B">
                  <enum>(5)</enum>
                  <header>Final sunscreen order</header>
                  <text>With respect to a proposed sunscreen order under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:a/p:1/sp:B" entity-type="act">paragraph (1)(B)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:a/p:2" entity-type="act">(2)</cato:entity-ref>—</text>
                  <subparagraph id="id2C84A44F3E904DE18A6D314A5C21AFF2">
                    <enum>(A)</enum>
                    <text>the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall issue a final sunscreen order—</text>
                    <clause id="id3FFEBD580FBA4D30A0ACCCD6872256B5">
                      <enum>(i)</enum>
                      <text>in the case of a proposed sunscreen order described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586/p:7/sp:A" entity-type="act">subparagraph (A)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586/p:7/sp:B" entity-type="act">(B) of section 586(7)</cato:entity-ref>,
			 not later than 90 calendar days after the end of the
			 public
			 comment period under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:a/p:3" entity-type="act">paragraph (3)</cato:entity-ref>; or</text>
                    </clause>
                    <clause id="idC12ADD05C9064ABDA91642DD1ED21325">
                      <enum>(ii)</enum>
                      <text>in the case of a proposed sunscreen order described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586/p:7/sp:C" entity-type="act">subparagraph (C) of section 586(7)</cato:entity-ref>, not
			 later than 210
			 calendar days after the date on which the sponsor submits the additional
			 information requested pursuant to such proposed sunscreen order; or</text>
                    </clause>
                  </subparagraph>
                  <subparagraph id="H7318B3DE3C50453D95D1AA62B40CFF0E">
                    <enum>(B)</enum>
                    <text>if the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> does not issue such final sunscreen order within such 90- or 210-calendar-day
			 period, as applicable,
			 the sponsor of such request may notify the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Office of the Commissioner" entity-parent-id="7524">Office of the Commissioner</cato:entity-ref> of
			 such request and request 
			 review by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Office of the Commissioner" entity-parent-id="7524">Office of the Commissioner</cato:entity-ref>.</text>
                  </subparagraph>
                </paragraph>
                <paragraph id="H7B1FEF4D3A0B4E74A456286BFAB1BFE6">
                  <enum>(6)</enum>
                  <header>Final sunscreen order by Commissioner</header>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Commissioner</cato:entity-ref> shall issue a final sunscreen order with respect to a proposed sunscreen order
			 subject to
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:a/p:5/sp:B" entity-type="act">paragraph
			 (5)(B)</cato:entity-ref> not later than 60 calendar days after the date of notification
			 under such paragraph.</text>
                </paragraph>
              </subsection>
              <subsection id="HA7688BA706F145989C59539F5C3E311C">
                <enum>(b)</enum>
                <header>Review of pending requests</header>
                <paragraph id="H3BD3BDD321F047E09F7D37CC325E8296">
                  <enum>(1)</enum>
                  <header>In general</header>
                  <text display-inline="yes-display-inline">The review of a pending request shall be carried out by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> in accordance with this
			 subsection.</text>
                </paragraph>
                <paragraph id="H38C3A27613FC48CDB1372C6396E9B1A4">
                  <enum>(2)</enum>
                  <header>Inapplicability of sections 586A and 586B</header>
                  <text display-inline="yes-display-inline">
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586A" entity-type="act">Sections 586A</cato:entity-ref> and  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B" entity-type="act">586B</cato:entity-ref> shall not apply with respect to any pending request.</text>
                </paragraph>
                <paragraph id="H37261EE29BD841839E41C39620411741">
                  <enum>(3)</enum>
                  <header>Feedback letters as proposed sunscreen order</header>
                  <text>Notwithstanding the requirements of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586/p:7" entity-type="act">section 586(7)</cato:entity-ref>, a letter issued pursuant to
			 section
			 330.14(g) of title 21, Code of Federal Regulations before the date of
			 enactment of the <short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                    </short-title>, with respect to a pending request, shall be deemed to be a proposed
			 sunscreen order  and displayed on the Internet website of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Food  and
			 Drug Administration</cato:entity-ref>.  Notification of the availability of such letter
			 shall be published in the Federal Register  not later
			 than 45
			 calendar days after the date of enactment of such Act.</text>
                </paragraph>
                <paragraph id="id8501F1CDA2F94DF9A41CD93059D1F416">
                  <enum>(4)</enum>
                  <header>Proposed sunscreen order</header>
                  <text display-inline="yes-display-inline">In the case of a pending request for which the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> has not issued a
			 letter pursuant to <external-xref legal-doc="usc" parsable-cite="usc/21/330">section 330.14(g)</external-xref> of title 21, Code of Federal
			 Regulations before the date of enactment of the <short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                    </short-title>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall complete review of such
			 request and, not later than 90 calendar days after the date of enactment
			 of such Act, issue a
			 proposed sunscreen order with respect to such request.</text>
                </paragraph>
                <paragraph id="H80440A15631B45BAAAE93360F36D3407">
                  <enum>(5)</enum>
                  <header>Proposed sunscreen order by Commissioner</header>
                  <text display-inline="yes-display-inline">If the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> does not issue a proposed sunscreen order under	<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:4" entity-type="act">paragraph (4)</cato:entity-ref>, or the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> does not publish a notification of the availability of a letter
			 under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:3" entity-type="act">paragraph (3)</cato:entity-ref>, as applicable, the
			 sponsor of such request may notify
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Office of the Commissioner" entity-parent-id="7524">Office of the Commissioner</cato:entity-ref> of such request and request review by the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Office of the Commissioner" entity-parent-id="7524">Office of the Commissioner</cato:entity-ref>. The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Commissioner</cato:entity-ref> shall, not
			 later than 60
			 calendar days after the date of
			 notification under this paragraph, issue a proposed order with respect to
			 such request.</text>
                </paragraph>
                <paragraph commented="no" id="H5127E59E083A44E7AC4B7FF2D4397664">
                  <enum>(6)</enum>
                  <header>Public comment period</header>
                  <text>A proposed sunscreen order issued under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:4" entity-type="act">paragraph (4)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:5" entity-type="act">(5)</cato:entity-ref>, or a notification of the availability
			 of a letter under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:3" entity-type="act">paragraph (3)</cato:entity-ref>, with respect to a pending
			 request
			 shall provide for a period of 45 calendar days for public
			 comment.</text>
                </paragraph>
                <paragraph id="HB2EE62CE47304127A22AC6D06D6D7934">
                  <enum>(7)</enum>
                  <header>Meeting</header>
                  <text>A sponsor may request, in writing, a meeting with respect to a proposed sunscreen order
			 issued under this subsection, including a letter deemed to be
			 a proposed sunscreen order under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:3" entity-type="act">paragraph (3)</cato:entity-ref>,
			 not later than 30 calendar days after the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> issues such order or
			 the date upon which such feedback letter is deemed to be  a proposed
			 sunscreen order, as applicable.  The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall convene a meeting
			 with such sponsor
			 not later than 45 calendar days after
			 the date of such request for a meeting.</text>
                </paragraph>
                <paragraph id="idAD186E64563E4FF5AA408F85F3D23CB8">
                  <enum>(8)</enum>
                  <header>Advisory committee</header>
                  <text>In the case of a proposed sunscreen order under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:3" entity-type="act">paragraph (3)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:4" entity-type="act">(4)</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:5" entity-type="act">(5)</cato:entity-ref>, an <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-parent-id="7524" value="Nonprescription Drug Advisory Committee" entity-type="federal-body">Advisory
			 Committee</cato:entity-ref>
			 meeting may be convened for the purpose of reviewing and providing
			 recommendations regarding the pending
			 request.</text>
                </paragraph>
                <paragraph commented="no" id="H93C4EE7CBFA74E5C8F4B246F1E82F0DC">
                  <enum>(9)</enum>
                  <header>Final sunscreen order</header>
                  <text>In the case of a proposed sunscreen order under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:3" entity-type="act">paragraph (3)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:4" entity-type="act">(4)</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:5" entity-type="act">(5)</cato:entity-ref>—</text>
                  <subparagraph commented="no" id="H20BF1528DCA747838D0D7F05A237EF61">
                    <enum>(A)</enum>
                    <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall issue a final sunscreen order with respect to the request—</text>
                    <clause commented="no" id="H0A8A6B4D0EF546159D68E589DB120E15">
                      <enum>(i)</enum>
                      <text>in the case of a proposed sunscreen order described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586/p:7/sp:A" entity-type="act">subparagraph (A)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586/p:7/sp:B" entity-type="act">(B) of section 586(7)</cato:entity-ref>,
			 not later than 90 calendar days after the end of the
			 public
			 comment period under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:6" entity-type="act">paragraph (6)</cato:entity-ref>; or</text>
                    </clause>
                    <clause commented="no" id="H9C1C3FA15CED473DA943839692504889">
                      <enum>(ii)</enum>
                      <text>in the case of a proposed sunscreen order described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586/p:7/sp:C" entity-type="act">subparagraph (C) of section 586(7)</cato:entity-ref>—</text>
                      <subclause id="H83063B7B932548EF802ECEB235627C54">
                        <enum>(I)</enum>
                        <text>if the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-parent-id="7524" value="Nonprescription Drug Advisory Committee" entity-type="federal-body">Advisory Committee</cato:entity-ref> is not convened under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:8" entity-type="act">paragraph (8)</cato:entity-ref>, not later than 210 calendar days
			 after
			 the date on which the sponsor submits the additional information requested
			 pursuant to such proposed sunscreen order, which shall include a rationale
			 for not convening such <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-parent-id="7524" value="Nonprescription Drug Advisory Committee" entity-type="federal-body">Advisory Committee</cato:entity-ref>; or</text>
                      </subclause>
                      <subclause id="HBA9F74DC30174E5D8354BE1CD3E38770">
                        <enum>(II)</enum>
                        <text>if the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-parent-id="7524" value="Nonprescription Drug Advisory Committee" entity-type="federal-body">Advisory Committee</cato:entity-ref> is convened under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:8" entity-type="act">paragraph (8)</cato:entity-ref>, not later than 270 calendar days after
			 the date
			 on which the sponsor submits such additional information; or</text>
                      </subclause>
                    </clause>
                  </subparagraph>
                  <subparagraph commented="no" id="H687B738086F94B1993224B50043EB2A0">
                    <enum>(B)</enum>
                    <text>if the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> does not issue such final sunscreen order within such 90-, 210-, or
			 270-calendar-day period, as
			 applicable, the sponsor of such request may notify the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Office of the Commissioner" entity-parent-id="7524">Office of the
			 Commissioner</cato:entity-ref> about such request and  request review by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Office of the Commissioner" entity-parent-id="7524">Office of the
			 Commissioner</cato:entity-ref>.</text>
                  </subparagraph>
                </paragraph>
                <paragraph id="H60FF9D52425F4FC5BF5CE00BFA876C53">
                  <enum>(10)</enum>
                  <header>Final sunscreen order by Commissioner</header>
                  <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Commissioner</cato:entity-ref> shall issue a final sunscreen order with respect to a proposed sunscreen order
			 subject to
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:9/sp:B" entity-type="act">paragraph
			 (9)(B)</cato:entity-ref> not later than 60 calendar days after the date of notification
			 under such paragraph.</text>
                </paragraph>
              </subsection>
              <subsection commented="no" id="H84AB83808E894A21903627CADDADCC92">
                <enum>(c)</enum>
                <header>Advisory committee</header>
                <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall not be required to—</text>
                <paragraph commented="no" id="H3CA6FFDB8B4F43319315F15024D65390">
                  <enum>(1)</enum>
                  <text>convene the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-parent-id="7524" value="Nonprescription Drug Advisory Committee" entity-type="federal-body">Advisory Committee</cato:entity-ref>—</text>
                  <subparagraph commented="no" id="H9D6177CFDB854FA4B8A17B4B2204473D">
                    <enum>(A)</enum>
                    <text>more than once with respect to any request under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586A" entity-type="act">section 586A</cato:entity-ref> or any pending request; or</text>
                  </subparagraph>
                  <subparagraph commented="no" id="H8788C90D99D04837B572F2BF13371688">
                    <enum>(B)</enum>
                    <text>more than twice in any calendar year with respect to the review under this
			 section; or</text>
                  </subparagraph>
                </paragraph>
                <paragraph commented="no" id="H54E30C8201174813857F1FF14A2B9F96">
                  <enum>(2)</enum>
                  <text>submit more than a total of 3 requests under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586A" entity-type="act">section 586A</cato:entity-ref> or pending requests to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-parent-id="7524" value="Nonprescription Drug Advisory Committee" entity-type="federal-body">Advisory
			 Committee</cato:entity-ref> per meeting.</text>
                </paragraph>
              </subsection>
              <subsection id="H27A1C5667E794BE28E28CBE3938546F7">
                <enum>(d)</enum>
                <header>No delegation</header>
                <text display-inline="yes-display-inline">Any responsibility vested in the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Commissioner</cato:entity-ref> by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:a/p:2" entity-type="act">subsection (a)(2)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:a/p:6" entity-type="act">(a)(6)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:5" entity-type="act">(b)(5)</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b/p:10" entity-type="act">(b)(10)</cato:entity-ref>
			 shall
			 not be delegated.</text>
              </subsection>
              <subsection commented="no" id="H94D08C45BBD84EEF88E130748730A07C">
                <enum>(e)</enum>
                <header>Effect of final sunscreen order</header>
                <paragraph commented="no" id="id334483B7BD1D4D2CA702D5442D425A39">
                  <enum>(1)</enum>
                  <header>In general</header>
                  <subparagraph commented="no" id="H00549ECC36894AEE83BED22DC73F7F28">
                    <enum>(A)</enum>
                    <header>Sunscreen active ingredients determined to be GRASE</header>
                    <text display-inline="yes-display-inline">Upon issuance of a final sunscreen order determining that a nonprescription sunscreen active
			 ingredient or
			 combination of nonprescription sunscreen active ingredients is GRASE and
			 is not misbranded, a sunscreen containing such ingredient
			 or combination of
			 ingredients shall be permitted to be introduced or
			 delivered
			 into
			 interstate commerce for use under the conditions described in such final
			 sunscreen order, in accordance with all requirements applicable to drugs
			 not subject
			 to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1">section 503(b)(1)</cato:entity-ref>, for so long as such final sunscreen order remains
			 in effect.</text>
                  </subparagraph>
                  <subparagraph commented="no" id="HBCF601F1218E4C3BBBF7ECF676E9E470">
                    <enum>(B)</enum>
                    <header>Sunscreen active ingredients determined not to be GRASE</header>
                    <text display-inline="yes-display-inline">Upon issuance of a final sunscreen order determining that a nonprescription sunscreen active
			 ingredient or
			 combination of nonprescription sunscreen active ingredients is not GRASE
			 and is misbranded, a sunscreen containing such ingredient
			 or combination of
			 ingredients shall not be introduced or delivered into
			 interstate
			 commerce,
			 for use under the conditions described in such final sunscreen order,
			 unless
			 an
			 application is approved pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/s:505" entity-type="act">section 505</cato:entity-ref> with respect to a
			 sunscreen containing such ingredient or combination of ingredients, or
			 unless conditions are later established under which such
			 ingredient or combination of ingredients is
			 later determined to be GRASE and not misbranded under the
			 over-the-counter drug monograph system.</text>
                  </subparagraph>
                </paragraph>
                <paragraph commented="no" id="id59848B53A5D04DC5A60FE5F467840146">
                  <enum>(2)</enum>
                  <header>Amendments to final sunscreen orders</header>
                  <subparagraph id="id080d3341c1e945f6895a1357dd686313">
                    <enum>(A)</enum>
                    <header>Amendments at initiative of Secretary</header>
                    <text>In the event that information relevant to a nonprescription sunscreen active ingredient or
			 combination of nonprescription sunscreen active ingredients becomes
			 available to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> after
			 issuance of a final sunscreen order, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> may amend such
			 final sunscreen order by issuing a new proposed sunscreen order under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:a/p:1" entity-type="act">subsection (a)(1)</cato:entity-ref> and following the procedures set forth in this section.</text>
                  </subparagraph>
                  <subparagraph id="id99857350cb394faab8381bb7d812ef1e">
                    <enum>(B)</enum>
                    <header>Petition to amend final order</header>
                    <text>Any interested person may petition the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> to amend a final sunscreen order under section
			 10.30, title 21 Code of Federal Regulations (or any successor
			 regulations).
			  If the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> grants any petition under such section, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref>
			 shall 
						 initiate the process for amending a final
			 sunscreen order by issuing a new proposed sunscreen order under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:a/p:1" entity-type="act">subsection (a)(1)</cato:entity-ref> and following the procedures set forth in
			 this section.</text>
                  </subparagraph>
                  <subparagraph id="idce2b20054a0a414ca1b0273c8034174d">
                    <enum>(C)</enum>
                    <header>Applicability of final orders</header>
                    <text>Once the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> issues a new proposed sunscreen order to amend a final sunscreen order under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:e/p:2/sp:A" entity-type="act">subparagraph (A)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:e/p:2/sp:B" entity-type="act">(B)</cato:entity-ref>, such final sunscreen order shall remain in effect
			 and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:e/p:3" entity-type="act">paragraph (3)</cato:entity-ref> shall not apply to such final
			 sunscreen order until the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> has issued a new final sunscreen order
			 or has determined not to amend the final sunscreen order.</text>
                  </subparagraph>
                </paragraph>
                <paragraph id="id7387D1AF10864E99AA2795221AFF5B77">
                  <enum>(3)</enum>
                  <header>Inclusion of Ingredients that are subjects of Final Orders in the Sunscreen Monograph</header>
                  <subparagraph id="id2fc57f05b98544b58bd8b39b26270f11">
                    <enum>(A)</enum>
                    <header>Amending regulations</header>
                    <clause id="idD5F35078CE9640BABDBB8FDE39BDC7D9">
                      <enum>(i)</enum>
                      <header>Requirement</header>
                      <text>At any time that the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> proposes to amend part 352 of title 21, Code of Federal
			 Regulations (or any successor regulations) concerning nonprescription
			 sunscreen, including pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586E" entity-type="act">section 586E</cato:entity-ref>, except as provided in
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:e/p:3/sp:A/cl:iv" entity-type="act">clause
			 (iv)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall include in such part 352 (or any successor
			 regulations) any nonprescription sunscreen active
			 ingredient or combination of nonprescription sunscreen active ingredients
			 that is the subject of an  effective final sunscreen order of the type
			 described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586/p:2/sp:A" entity-type="act">section 586(2)(A)</cato:entity-ref> and issued since the time that the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> last amended
			 such regulations. Such regulation shall set forth conditions of use under
			 which each such ingredient or combination of ingredients is GRASE and not
			 misbranded. If these conditions differ from, or are in addition to, those
			 previously set forth in the applicable final sunscreen order, the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall provide notice and opportunity for comment on such
			 conditions in the rulemaking, and the applicable final sunscreen order
			 shall continue in effect until the effective date of a final regulation,
			 as set forth in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:e/p:3/sp:A/cl:iii" entity-type="act">clause (iii)</cato:entity-ref>.</text>
                    </clause>
                    <clause id="idB53B7276589B4393B13981E5BE81CAA6">
                      <enum>(ii)</enum>
                      <header>Inclusion of orders</header>
                      <text>In proposing to amend the regulations as described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:e/p:3/sp:A/cl:i" entity-type="act">clause (i)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall include in
			 the proposed
			 regulations a list of final sunscreen orders that shall cease to be
			 effective on the effective date of a resulting final regulation.  Such
			 list shall
			 include all final sunscreen orders of the type described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586/p:2/sp:A" entity-type="act">section
			 586(2)(A)</cato:entity-ref> that are in effect
			 on the date that such
			 regulations are proposed, with the exception that such list shall not
			 include any
			 final sunscreen orders that, on the date that the regulations are
			 proposed, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> is in the process of amending
			 under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:e/p:2" entity-type="act">paragraph (2)</cato:entity-ref>.</text>
                    </clause>
                    <clause id="id2CFA474B1FC144879C6877408828160A">
                      <enum>(iii)</enum>
                      <header>Orders no longer effective</header>
                      <text>Any final sunscreen order included by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> in a list described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:e/p:3/sp:A/cl:ii" entity-type="act">clause (ii)</cato:entity-ref> and in a
			 list included in resulting final regulations shall cease
			 to be effective on the date that such final regulations including such
			 order
			 in such list become effective.</text>
                    </clause>
                    <clause id="id17DBF00423474C76939A5E4422B52CAD">
                      <enum>(iv)</enum>
                      <header>Ingredients not GRASE</header>
                      <text>If, notwithstanding a final sunscreen order stating that a nonprescription sunscreen active
			 ingredient or combination of nonprescription sunscreen active ingredients
			 is GRASE and is not misbranded if marketed in accordance with such order,
			 while
			 amending the regulations as described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:e/p:3/sp:A/cl:i" entity-type="act">clause (i)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref>
			 concludes that such ingredient or combination of ingredients is no longer
			 GRASE for use in nonprescription sunscreen, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall, at the
			 discretion of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref>, either initiate the process for amending the
			 final sunscreen order set forth in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:e/p:2" entity-type="act">paragraph (2)</cato:entity-ref> of this subsection or
			 include in a proposed regulation an explanation and information supporting
			 the determination of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> that such ingredient or combination of
			 ingredients is no longer GRASE for use in nonprescription sunscreen.</text>
                    </clause>
                  </subparagraph>
                  <subparagraph id="id1e5d7970e66547b581817d28ad6b80c8">
                    <enum>(B)</enum>
                    <header>Procedure for updating regulations</header>
                    <text>After the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> amends and finalizes the regulations under part 352 of title 21, Code of
			 Federal Regulations under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586E" entity-type="act">section
			 586E</cato:entity-ref> and such regulations become effective, the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> may use direct final
			 rulemaking to include in such regulations any nonprescription sunscreen
			 active ingredients that are the subject of effective final sunscreen
			 orders.</text>
                  </subparagraph>
                </paragraph>
              </subsection>
            </section>
            <section id="id843CAB23CA8548F495159CE6187CE59C">
              <enum>586D.</enum>
              <header>Guidance; other provisions</header>
              <subsection commented="no" id="H9494AAFD409843B88EF852551458FEBB">
                <enum>(a)</enum>
                <header>Guidance</header>
                <paragraph commented="no" id="idB085F425B52D4DD6BB5D8232127B2854">
                  <enum>(1)</enum>
                  <header>In general</header>
                  <subparagraph commented="no" id="HEB968F1841374E7A90F367EBD4B91B7B">
                    <enum>(A)</enum>
                    <header>Draft guidance</header>
                    <text>Not later than 1 year after the date of enactment of the <short-title>
                        <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                      </short-title>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall issue draft
			 guidance on the
			 implementation of, and compliance with, the requirements with respect to
			 sunscreen under this subchapter, including
			 guidance on—</text>
                    <clause commented="no" id="H7FCB962D05E648D0971D0476B733634F">
                      <enum>(i)</enum>
                      <text>the format and content of information submitted by a sponsor in support of a request under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586A" entity-type="act">section 586A</cato:entity-ref> or a pending request;</text>
                    </clause>
                    <clause commented="no" id="H0F3E93EE992449769428956EE9A83BEC">
                      <enum>(ii)</enum>
                      <text display-inline="yes-display-inline">the data required to meet the safety and efficacy standard for determining whether a
			 nonprescription sunscreen active
			 ingredient or combination of nonprescription sunscreen active ingredients
			 is GRASE and is not misbranded;</text>
                    </clause>
                    <clause commented="no" id="id50D8E003E6C14FFAA107557664AD91E6">
                      <enum>(iii)</enum>
                      <text>the process by which a request under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586A" entity-type="act">section 586A</cato:entity-ref> or a pending request is withdrawn; and</text>
                    </clause>
                    <clause commented="no" id="id19DB6BBD21D1453FBA84CF07146B7FCD">
                      <enum>(iv)</enum>
                      <text>the process by which the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> will carry out <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:c" entity-type="act">section 586C(c)</cato:entity-ref>, including with respect to how
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> will address the total number of requests received under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586A" entity-type="act">section 586A</cato:entity-ref> and pending requests.</text>
                    </clause>
                  </subparagraph>
                  <subparagraph commented="no" id="H8112AA8A6E114B859DEC8EC02809A3A7">
                    <enum>(B)</enum>
                    <header>Final guidance</header>
                    <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall finalize the guidance described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586D/ss:a/p:1/sp:A" entity-type="act">subparagraph (A)</cato:entity-ref> not later than 2 years
			 after
			 the date of enactment of the <short-title>
                        <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                      </short-title>.</text>
                  </subparagraph>
                  <subparagraph commented="no" id="idC498EC6BE90C4846B6AB75C81C455F09">
                    <enum>(C)</enum>
                    <header>Inapplicability of Paperwork Reduction Act</header>
                    <text display-inline="yes-display-inline">
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="usc-chapter/44/35" entity-type="uscode">
                        <external-xref legal-doc="usc-chapter" parsable-cite="usc-chapter/44/35">Chapter 35</external-xref> of title 44, United States Code</cato:entity-ref> shall not apply to collections of information made for
			 purposes of guidance under this subsection.</text>
                  </subparagraph>
                </paragraph>
                <paragraph commented="no" id="HB85EB463F0344DDAB8415EBBB4E73E67">
                  <enum>(2)</enum>
                  <header>Submissions pending issuance of final guidance</header>
                  <text>Irrespective of whether final guidance under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586D/ss:a/p:1" entity-type="act">paragraph (1)</cato:entity-ref> has been issued—</text>
                  <subparagraph commented="no" id="HE96198B929B04E21A328030F3E8EE86C">
                    <enum>(A)</enum>
                    <text display-inline="yes-display-inline">persons may, beginning on the date of enactment of the <short-title>
                        <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                      </short-title>, make submissions under this
			 subchapter; and</text>
                  </subparagraph>
                  <subparagraph commented="no" id="H4681768AC0254F2185537E7254E2D695">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref>
			 shall review and act upon such submissions in accordance with this
			 subchapter.</text>
                  </subparagraph>
                </paragraph>
              </subsection>
              <subsection id="HD6748E7656E2458EA657AB6130919125">
                <enum>(b)</enum>
                <header>Rules of construction</header>
                <paragraph id="idCE500D29933E4CBE90FD7DB233BDAE38">
                  <enum>(1)</enum>
                  <header>Currently marketed sunscreens</header>
                  <text>Nothing in this subchapter shall be construed to affect the marketing of sunscreens that are
			 marketed in interstate commerce on or before the date of enactment
			 of this subchapter, except as otherwise provided in this subchapter.</text>
                </paragraph>
                <paragraph id="HCE4EEAA6EB754A8087F34516B778D774">
                  <enum>(2)</enum>
                  <header>Ensuring safety and effectiveness</header>
                  <text>Nothing in this subchapter shall be construed to alter the authority of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> with respect
			 to prohibiting the
			 marketing of a sunscreen that is not safe and
			 effective or is misbranded, or
			 with respect to imposing
			 restrictions on the marketing of a sunscreen to ensure safety and
			 effectiveness, except as otherwise provided in this subchapter, including
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:e" entity-type="act">section 586C(e)</cato:entity-ref>.</text>
                </paragraph>
                <paragraph id="H5BEECF977A7D42D0BAB82113792C95BE">
                  <enum>(3)</enum>
                  <header>Other drugs</header>
                  <text>Except as otherwise provided in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F" entity-type="act">section 586F</cato:entity-ref>, nothing in this subchapter shall
			 be construed to affect the authority of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> under this Act or
			 the <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                      <cato:entity-ref entity-type="act" value="Public Health Service Act">Public Health Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/201/etseq">42
			 U.S.C. 201 et seq.</cato:entity-ref>)</cato:entity> with respect to a drug  other than a nonprescription
			 sunscreen.</text>
                </paragraph>
                <paragraph commented="no" id="id53BD0ED91DD94580AAB06C3F6EB31EF6">
                  <enum>(4)</enum>
                  <header>Effect on drugs otherwise approved</header>
                  <text>Nothing in this subchapter shall affect the marketing of a drug approved under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/s:505" entity-type="act">section 505</cato:entity-ref> of this
			 Act or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Public Health Service Act/s:351" entity-type="act">section 351 of the Public Health Service Act</cato:entity-ref>.</text>
                </paragraph>
              </subsection>
              <subsection id="iddf83ff67b254451dae6013710bfdcc98">
                <enum>(c)</enum>
                <header>Timelines</header>
                <text>The timelines for the processes and
			 procedures under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:a/p:1" entity-type="act">paragraphs (1)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:a/p:2" entity-type="act">(2)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:a/p:5" entity-type="act">(5)</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:a/p:6" entity-type="act">(6) of section 586C(a)</cato:entity-ref>
			 shall not apply to any requests submitted to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586A" entity-type="act">section
			 586A</cato:entity-ref> after the date that is 6 years after the date of enactment of the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                  </short-title>.</text>
              </subsection>
            </section>
            <section id="id12FD432FE1854955B95667F4179258B6">
              <enum>586E.</enum>
              <header>Sunscreen monograph</header>
              <subsection id="id8124F80617C843D892006FC21D6A833E">
                <enum>(a)</enum>
                <header>In general</header>
                <text>Not later than 5 years after the date of enactment of the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                  </short-title>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall amend and finalize regulations under part 352 of title 21, Code of
			 Federal Regulations concerning nonprescription  sunscreen that are
			 effective not later than 5 years after such date of enactment. The
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall publish such regulations not less than 30 calendar days
			 before the effective date of such regulations.</text>
              </subsection>
              <subsection id="idd0f31ec17fa84c7bb56ab0d5dc3394a7">
                <enum>(b)</enum>
                <header>Reports</header>
                <text>If the regulations promulgated under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586E/ss:a" entity-type="act">subsection (a)</cato:entity-ref> do not include provisions related to the
			 effectiveness of various sun protection factor levels, and do not address
			 all dosage forms known to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> to be used in sunscreens marketed
			 in the United States without a new drug approval under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/s:505" entity-type="act">section 505</cato:entity-ref>, the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall submit a report to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="SSHR00" entity-type="committee">Committee on Health, Education,
			 Labor, and Pensions of the Senate</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="HIF00" entity-type="committee">Committee on Energy and Commerce
			 of the House of Representatives</cato:entity-ref> on the rationale for such provisions not
			 being included in such regulations, and a plan and timeline to compile any
			 information necessary to address such provisions through final
			 regulations.</text>
              </subsection>
            </section>
          </subchapter>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
      </subsection>
      <subsection id="id3841C9A948FC46FDA1F7FD40030868F3">
        <enum>(b)</enum>
        <header>Rules of construction</header>
        <text>Nothing in the amendment made by this section shall be construed to—</text>
        <paragraph id="idE2C18667D5504E229CC3187521C8D4F1">
          <enum>(1)</enum>
          <text>limit the right of a sponsor
			 (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586/p:8" entity-type="act">section 586(8) of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref>,
			 as added by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Sunscreen Innovation Act/s:2/ss:a" entity-type="act">subsection (a)</cato:entity-ref>) to request that the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary of Health and
			 Human
			 Services</cato:entity-ref> convene an advisory committee; or</text>
        </paragraph>
        <paragraph id="idCBBB4AECB33647C6B29A72B8D94807D3">
          <enum>(2)</enum>
          <text>limit the authority of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary of Health and Human Services</cato:entity-ref> to meet with a sponsor (as
			 defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586/p:8" entity-type="act">section 586(8) of the
			 Federal Food, Drug, and Cosmetic Act</cato:entity-ref>, as added by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Sunscreen Innovation Act/s:2/ss:a" entity-type="act">subsection (a)</cato:entity-ref>).</text>
        </paragraph>
      </subsection>
    </section>
    <section changed="added" commented="no" committee-id="SSHR00" id="id3B3805A406254F4C889B168CAEA3F697" reported-display-style="italic">
      <enum>3.</enum>
      <header>Non-sunscreen time and extent applications</header>
      <text display-inline="no-display-inline">
        <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/ch:V/sch:I" entity-type="act">Subchapter I of chapter V of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref>, as added by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Sunscreen Innovation Act/s:2" entity-type="act">section 2</cato:entity-ref>, is
			 amended by adding at the end the following:</text>
      <quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idC15CC0CC92FE446092D9D8441AF9DD6A" reported-display-style="italic" style="OLC">
        <section id="id524AFD43C3AA4BA7A4CD9C9E26914ED7">
          <enum>586F.</enum>
          <header>Non-sunscreen time and extent applications</header>
          <subsection commented="no" id="idBEBDE22D9AF44DF6908AAB01DF953D39">
            <enum>(a)</enum>
            <header>Pending time and extent applications</header>
            <paragraph id="id66DCC63F3D3D41B4A5B29245C965ACAF">
              <enum>(1)</enum>
              <header>In general</header>
              <subparagraph id="id473FC6EBE4464F00AD2534EB59909423">
                <enum>(A)</enum>
                <header>Request for framework for review</header>
                <text>If, prior to the date of enactment of the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                  </short-title>, an application was submitted pursuant to <external-xref legal-doc="regulation" parsable-cite="cfr/21/330.14">section 330.14</external-xref> of title 21, Code of Federal Regulations
			 for a GRASE determination for a drug other than a nonprescription
			 sunscreen active
			 ingredient
			 or combination of nonprescription sunscreen active ingredients and such
			 drug was found to be eligible to be considered for
			 inclusion
			 in the over-the-counter drug monograph system pursuant to section 330.14
			 of
			 title 21, Code of Federal Regulations, the
			 sponsor of such application may request that the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> provide a
			 framework under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:2" entity-type="act">paragraph (2)</cato:entity-ref> for the review of such application.</text>
              </subparagraph>
              <subparagraph id="id68D83B46E6B645F2B216056989AE2A7F">
                <enum>(B)</enum>
                <header>Request requirements</header>
                <text>A request for a framework for review of an application made under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1/sp:A" entity-type="act">subparagraph (A)</cato:entity-ref> shall be made
			 within 180 calendar days of the date of
			 enactment of the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                  </short-title> and shall include the preference of such sponsor as to whether such application is reviewed by the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> in accordance with—</text>
                <clause id="id2441B7F30B894BC3AD898F32D46F899B">
                  <enum>(i)</enum>
                  <text>the processes and procedures set forth for pending requests under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b" entity-type="act">section 586C(b)</cato:entity-ref>, except that
			 specific timelines shall be determined  in accordance with other
			 applicable requirements under this section;</text>
                </clause>
                <clause id="idAF6FED06205240BC9F1D8424C9370799">
                  <enum>(ii)</enum>
                  <text>the processes and procedures set forth under part 330 of title 21, Code of Federal Regulations
			 (or any successor regulations);</text>
                </clause>
                <clause id="id9C49AD9C7D064BBB804E30E17C049F3D">
                  <enum>(iii)</enum>
                  <text>an initial filing determination under the processes and procedures described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b" entity-type="act">section 586B(b)</cato:entity-ref> and
			 the processes and procedures set forth for pending requests under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b" entity-type="act">section
			 586C(b)</cato:entity-ref>, except that
			 specific timelines shall be determined  in accordance with other
			 applicable requirements under this section; or</text>
                </clause>
                <clause id="idB70624DEFCFF4B70A128294EAAF39B5E">
                  <enum>(iv)</enum>
                  <text>an initial filing determination under the processes and procedures described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b" entity-type="act">section 586B(b)</cato:entity-ref> and
			 the processes and procedures set forth under part 330 of title 21, Code
			 of Federal Regulations (or any successor regulations).</text>
                </clause>
              </subparagraph>
              <subparagraph id="id6D343716E32B4F069669BA62FE571CDD">
                <enum>(C)</enum>
                <header>No request</header>
                <text>If a sponsor described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1/sp:A" entity-type="act">subparagraph (A)</cato:entity-ref> does not make such request within 180 calendar days of
			 the date
			 of enactment of the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                  </short-title>, such application shall be reviewed by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref>
			 in accordance with the timelines of the applicable regulations when such
			 regulations are finalized under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:b" entity-type="act">subsection (b)</cato:entity-ref>.</text>
              </subparagraph>
            </paragraph>
            <paragraph id="idC5B1A443835B4C81AA61D6E428E71C01">
              <enum>(2)</enum>
              <header>Framework</header>
              <text>Not later than 1 year after the date of enactment of the <short-title>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                </short-title>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall provide, in writing, a framework to each sponsor that submitted a request
			 under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1" entity-type="act">paragraph (1)</cato:entity-ref>. Such framework shall set forth the various timelines,
			 in calendar days, with respect to the processes and procedures for review
			 under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1/sp:B/cl:i" entity-type="act">clauses (i)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1/sp:B/cl:ii" entity-type="act">(ii)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1/sp:B/cl:iii" entity-type="act">(iii)</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1/sp:B/cl:iv" entity-type="act">(iv) of paragraph (1)(B)</cato:entity-ref> and—</text>
              <subparagraph id="id074BC35F4B1341B686C2B757019B3FF1">
                <enum>(A)</enum>
                <text>such timelines shall account for
			 the considerations under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:5" entity-type="act">paragraph (5)</cato:entity-ref>; and</text>
              </subparagraph>
              <subparagraph id="idE2200C8A545F436B80F3E12F45D9A59B">
                <enum>(B)</enum>
                <text>the timelines for the various processes and procedures shall not be shorter than the timelines set
			 forth for pending requests under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586B/ss:b" entity-type="act">sections 586B(b)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C/ss:b" entity-type="act">586C(b)</cato:entity-ref>, as
			 applicable.</text>
              </subparagraph>
            </paragraph>
            <paragraph id="id5A909C409B074E0E8615348E6E0505A1">
              <enum>(3)</enum>
              <header>Governing processes and procedures for review</header>
              <subparagraph id="idA1821B574CF24C609FCA21B1A61444FF">
                <enum>(A)</enum>
                <header>Election</header>
                <text>Not later than 60 calendar days after the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> provides a framework to a sponsor under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:2" entity-type="act">paragraph (2)</cato:entity-ref>, such sponsor may provide an election to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref>
			 regarding the processes and procedures for review under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1/sp:B/cl:i" entity-type="act">clause (i)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1/sp:B/cl:ii" entity-type="act">(ii)</cato:entity-ref>,
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1/sp:B/cl:iii" entity-type="act">(iii)</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1/sp:B/cl:iv" entity-type="act">(iv) of paragraph (1)(B)</cato:entity-ref>.  If such sponsor makes such election,
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall review the application that is the subject of such
			 election pursuant to the processes and procedures elected by such sponsor
			 and the applicable timelines in calendar days set forth under such
			 framework, which the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall confirm in writing to the sponsor not
			 later than the date upon which the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> provides a report under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:4" entity-type="act">paragraph (4)</cato:entity-ref>.  If such sponsor does not make such election, such
			 application shall be reviewed by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> in accordance with the
			 timelines of the applicable regulations when such regulations are
			 finalized under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:b" entity-type="act">subsection (b)</cato:entity-ref>.</text>
              </subparagraph>
              <subparagraph id="idD3FA6557D06746458CCA9A453278B29A">
                <enum>(B)</enum>
                <header>Different processes and procedures</header>
                <text>At any time during review of an application, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> may review such application under
			 different processes and procedures under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1/sp:B/cl:i" entity-type="act">clause (i)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1/sp:B/cl:ii" entity-type="act">(ii)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1/sp:B/cl:iii" entity-type="act">(iii)</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1/sp:B/cl:iv" entity-type="act">(iv)
			 of paragraph (1)(B)</cato:entity-ref> than the processes and procedures the sponsor elected
			 in accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:3/sp:A" entity-type="act">subparagraph (A)</cato:entity-ref>, so long as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> proposes, in
			 writing,  the
			 change and the sponsor agrees, in writing, to such change.</text>
              </subparagraph>
              <subparagraph id="ideb22b74277594d149c3629c2c98d4b3a">
                <enum>(C)</enum>
                <header>Inclusion of ingredients in monographs</header>
                <text>If the sponsor elects to use the processes and procedures for review in accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1/sp:B/cl:i" entity-type="act">clause (i)</cato:entity-ref>
			 or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1/sp:B/cl:iii" entity-type="act">(iii) of paragraph
			 (1)(B)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> may incorporate any resulting final
			 order into a regulation addressing the conditions under which other drugs
			 in the same therapeutic category are GRASE and not misbranded, including
			 through direct final rulemaking, and the final order so incorporated shall
			 cease to be effective on the effective date of the final regulation that
			 addresses such drug.</text>
              </subparagraph>
            </paragraph>
            <paragraph id="idCF2015CED4CB45A3993A8C812F2636C8">
              <enum>(4)</enum>
              <header>Letter regarding pending applications</header>
              <text>Not later than 18 months after the date of enactment of the <short-title>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                </short-title>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall report to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="SSHR00" entity-type="committee">Committee on Health, Education, Labor, and Pensions of the
			 Senate</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="HIF00" entity-type="committee">Committee on Energy and Commerce of the House of
			 Representatives</cato:entity-ref>, in writing, regarding all pending applications subject to
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1" entity-type="act">paragraph (1)</cato:entity-ref>.  In such letter, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall provide a report on
			 the review of such applications, including the timelines, in
			 calendar days, for the review and GRASE determination for each
			 application. Such timelines shall account for the considerations under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:5" entity-type="act">paragraph (5)</cato:entity-ref>.</text>
            </paragraph>
            <paragraph id="idFBB8E005D7364E39B826EB091C054EA5">
              <enum>(5)</enum>
              <header>Timelines</header>
              <text>The timelines in calendar days established by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> pursuant to this subsection—</text>
              <subparagraph id="ida067ae3484f441a584e376a21afa88e3">
                <enum>(A)</enum>
                <text>may vary based on the content, complexity, and format of the application submitted to the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref>; and</text>
              </subparagraph>
              <subparagraph id="idfc027465d6aa46e881ecc9852b9c01a8">
                <enum>(B)</enum>
                <text>shall—</text>
                <clause id="id13fda1b370134563866c3d4478d9d4b7">
                  <enum>(i)</enum>
                  <text>reflect the public health priorities of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Food and Drug Administration</cato:entity-ref>, including the potential
			 public health benefits posed by the inclusion of additional drugs in the
			 over-the-counter drug monograph system;</text>
                </clause>
                <clause id="id506afcb677bb4b6285e59ceb9e110ddd">
                  <enum>(ii)</enum>
                  <text>take into consideration the resources available to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> for carrying out such	priorities
			 and the processes and procedures described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1/sp:B" entity-type="act">paragraphs (1)(B)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:2" entity-type="act">(2)</cato:entity-ref>;
			 and</text>
                </clause>
                <clause id="id35a371f498f348a9b09355cc88034053">
                  <enum>(iii)</enum>
                  <text>be reasonable, taking into consideration the requirements described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:5/sp:B/cl:i" entity-type="act">clauses (i)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:5/sp:B/cl:ii" entity-type="act">(ii)</cato:entity-ref>.</text>
                </clause>
              </subparagraph>
            </paragraph>
          </subsection>
          <subsection commented="no" id="id3AAA7BB545C2447DB14E930EA765558B">
            <enum>(b)</enum>
            <header>New time and extent applications</header>
            <paragraph id="idC3B54B651C49487CAC53B9CD047FBED5">
              <enum>(1)</enum>
              <header>In general</header>
              <text>Not later than 18 months after the date of enactment of the <short-title>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                </short-title>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall issue proposed regulations establishing timelines for the review of
			 applications for GRASE determinations for drugs other than nonprescription
			 sunscreen active ingredients or combinations of
			 nonprescription sunscreen active ingredients that are submitted to the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> after the date of enactment of the <short-title>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                </short-title>,  under <external-xref legal-doc="regulation" parsable-cite="cfr/21/330.14">section 330.14</external-xref> of title 21, Code of Federal Regulations (or any successor regulations),
			 and that are found to be eligible to be considered for inclusion in the
			 over-the-counter drug monograph system pursuant to section 330.14 of title
			 21, Code of Federal Regulations (or any successor regulations), or that
			 are subject to this subsection pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:1" entity-type="act">paragraph (1)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:a/p:3" entity-type="act">(3) of
			 subsection (a)</cato:entity-ref>, as applicable, providing—</text>
              <subparagraph id="idF33F940518FF4CDAA915CDAE89E13645">
                <enum>(A)</enum>
                <text>timely and efficient completion of evaluations of applications
			 under <external-xref legal-doc="regulation" parsable-cite="cfr/21/330.14">section 330.14</external-xref> of title 21, Code of Federal Regulations
			 (or any successor regulations) for drugs other than sunscreens; and</text>
              </subparagraph>
              <subparagraph id="idA1F2E37E7C6245A78A95D1B0BBC1AF98">
                <enum>(B)</enum>
                <text>timely and efficient completion of the review of the safety and effectiveness submissions pursuant
			 to
			 such applications, including establishing—</text>
                <clause id="id5D80580C780D4F6694685D9CCF4338B1">
                  <enum>(i)</enum>
                  <text>reasonable timelines, in calendar days, for the applicable proposed and final regulations for
			 applications of various content, complexity, and format, and
			 timelines for internal
			 procedures related to such processes; and</text>
                </clause>
                <clause id="id78E224138C5E4ADEB461DBC50AA11DBF">
                  <enum>(ii)</enum>
                  <text>measurable metrics for tracking the extent to which the timelines set forth in the regulations are
			 met.</text>
                </clause>
              </subparagraph>
            </paragraph>
            <paragraph id="idE6597ED4E9064EAE88F44176A526AE1A">
              <enum>(2)</enum>
              <header>Timelines</header>
              <text>The timelines in calendar days established in the regulations under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:b/p:1" entity-type="act">paragraph (1)</cato:entity-ref>—</text>
              <subparagraph id="idD74A7881CDFE4F72B99000AF63C41224">
                <enum>(A)</enum>
                <text>may vary based on the content, complexity, and format of the application submitted to the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref>; and</text>
              </subparagraph>
              <subparagraph id="id252A734CD3F34EAEB3767EF3CF614082">
                <enum>(B)</enum>
                <text>shall—</text>
                <clause id="id539BA422363F4CA4A5B8CEDC79B60A06">
                  <enum>(i)</enum>
                  <text>reflect the public health priorities of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Food and Drug Administration</cato:entity-ref>, including the potential
			 public health benefits posed by the inclusion of additional drugs in the
			 over-the-counter drug monograph system;</text>
                </clause>
                <clause id="id1ACC0AC2484F4B709DC45ED28BE69B1C">
                  <enum>(ii)</enum>
                  <text>take into consideration the resources available to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> for carrying out such priorities
			 and the processes and procedures described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:b/p:1" entity-type="act">paragraph (1)</cato:entity-ref>; and</text>
                </clause>
                <clause id="idC773B9E308064DF281EA97EF45507A47">
                  <enum>(iii)</enum>
                  <text>be reasonable, taking into consideration the requirements described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:b/p:2/sp:B/cl:i" entity-type="act">clauses (i)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:b/p:2/sp:B/cl:ii" entity-type="act">(ii)</cato:entity-ref>.</text>
                </clause>
              </subparagraph>
            </paragraph>
            <paragraph id="id66A09A88710347E18696E8EDC82416E9">
              <enum>(3)</enum>
              <header>Procedure</header>
              <text>In promulgating regulations under this subsection, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall issue a notice of proposed
			 rulemaking that includes a copy of the proposed regulation, provide a
			 period of not less than 60 calendar days for comments on the proposed
			 regulation, and
			 publish the final regulation not less than 30 calendar days before the
			 effective date of the regulation.</text>
            </paragraph>
            <paragraph id="ide0f5136264dd4c04a4575a05c717092f">
              <enum>(4)</enum>
              <header>Restrictions</header>
              <text>Notwithstanding any other provision of law, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall promulgate regulations implementing
			 this section only as described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:b/p:1" entity-type="act">paragraphs (1)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:b/p:2" entity-type="act">(2)</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586F/ss:b/p:3" entity-type="act">(3)</cato:entity-ref>.</text>
            </paragraph>
            <paragraph commented="no" id="idED1F5CB3644C4C3F8B842B2F768ED59D">
              <enum>(5)</enum>
              <header>Final regulations</header>
              <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall finalize the regulations under this section not later than 27 months after the
			 date of enactment of the <short-title>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                </short-title>.</text>
            </paragraph>
          </subsection>
        </section>
        <after-quoted-block>.</after-quoted-block>
      </quoted-block>
    </section>
    <section changed="added" commented="no" committee-id="SSHR00" id="H8EF08CBE438944569E8CC8623E7B93D8" reported-display-style="italic">
      <enum>4.</enum>
      <header>Reports</header>
      <subsection commented="no" id="id249B5C6226AD47AC893AFBF7E9D16806">
        <enum>(a)</enum>
        <header>Initial GAO report</header>
        <text display-inline="yes-display-inline">Not later than 3  years after the date of enactment of this Act, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="0500" entity-type="federal-body">Comptroller
			 General of the United States</cato:entity-ref> shall submit to
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="SSHR00" entity-type="committee">Committee on Health, Education, Labor, and Pensions of the Senate</cato:entity-ref> and
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="HIF00" entity-type="committee">Committee on Energy and Commerce of the House of Representatives</cato:entity-ref> a
			 report reviewing the overall
			 progress of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary of Health and Human Services</cato:entity-ref> in carrying out
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/ch:V/sch:I" entity-type="act">subchapter I of chapter V of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (as
			 added by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Sunscreen Innovation Act/s:2" entity-type="act">section 2</cato:entity-ref> and amended by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Sunscreen Innovation Act/s:3" entity-type="act">section 3</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Sunscreen Innovation Act/s:4/ss:c" entity-type="act">subsection (c)</cato:entity-ref>),
			 including findings on and recommendations with respect to—</text>
        <paragraph id="H2FBE91F6598D4E069124BB03C81F8F1C">
          <enum>(1)</enum>
          <text>the progress made in completing the review of requests under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/ch:V/sch:I" entity-type="act">subchapter I of chapter V of the
			 Federal Food, Drug, and Cosmetic Act</cato:entity-ref>, including pending requests, and the
			 feasibility of the timelines associated with such subchapter;</text>
        </paragraph>
        <paragraph id="H65546D25196C4398B8DBACA3366D724B">
          <enum>(2)</enum>
          <text>the role of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-parent-id="7524" value="Office of the Commissioner" entity-type="federal-body">Office of the Commissioner of Food and Drugs</cato:entity-ref> in issuing determinations with respect
			 to requests reviewed under such subchapter, including the number of
			 requests transferred to the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-parent-id="7524" value="Office of the Commissioner" entity-type="federal-body">Office of the Commissioner</cato:entity-ref> under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586C" entity-type="act">section 586C</cato:entity-ref> of such Act;</text>
        </paragraph>
        <paragraph id="id261d7278666c484d943f96f4e3de8802">
          <enum>(3)</enum>
          <text>the extent to which advisory committees were convened by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> regarding requests under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/ch:V/sch:I" entity-type="act">subchapter I of chapter V of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref>,
			 including pending requests; and</text>
        </paragraph>
        <paragraph id="id8ef6914028bf4d6c954ad9b82c4ecdec">
          <enum>(4)</enum>
          <text>the types of metrics that have been, or should be, established for the review of time and
			 extent applications.</text>
        </paragraph>
      </subsection>
      <subsection id="id5449A5989BE24113956CBD5FEF3876CC">
        <enum>(b)</enum>
        <header>Subsequent GAO report</header>
        <text>Not later than 5<fraction>1/2</fraction> years after the date of enactment of this Act, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="0500" entity-type="federal-body">Comptroller General of the
			 United States</cato:entity-ref> shall submit to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="SSHR00" entity-type="committee">Committee on Health, Education, Labor,
			 and Pensions of the Senate</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="HIF00" entity-type="committee">Committee on Energy and Commerce of the
			 House of Representatives</cato:entity-ref> a report reviewing the overall progress of the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary of Health and Human Services</cato:entity-ref> in carrying out <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/ch:V/sch:I" entity-type="act">subchapter I of
			 chapter V of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (as added by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Sunscreen Innovation Act/s:2" entity-type="act">section
			 2</cato:entity-ref> and amended by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Sunscreen Innovation Act/s:3" entity-type="act">section 3</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Sunscreen Innovation Act/s:4/ss:c" entity-type="act">subsection (c)</cato:entity-ref>) and the
			 regulation of over-the-counter drug products,
			 including findings on and recommendations with respect to—</text>
        <paragraph id="idd93ad7fa0d28454ebb21327efdb5a72f">
          <enum>(1)</enum>
          <text>updates on the matters reported on by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="0500" entity-type="federal-body">Comptroller General</cato:entity-ref> under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Sunscreen Innovation Act/s:4/ss:a" entity-type="act">subsection (a)</cato:entity-ref>;</text>
        </paragraph>
        <paragraph id="id2bface0f57a44ad480ab3b78f207326a">
          <enum>(2)</enum>
          <text>significant factors impacting the ability of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Food and Drug Administration</cato:entity-ref> to
			 fulfill the mission of the agency with regard to the regulation of
			 over-the-counter drug products, including finalizing outstanding
			 monographs and responding to emerging and novel safety issues;</text>
        </paragraph>
        <paragraph id="iddc0291862564468f8c65f03a0c5600bd">
          <enum>(3)</enum>
          <text>the performance of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> in carrying out <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586E" entity-type="act">section 586E of the Federal Food, Drug, and
			 Cosmetic
			 Act</cato:entity-ref>;</text>
        </paragraph>
        <paragraph id="idaac91c568f974963b40294eec96a48ed">
          <enum>(4)</enum>
          <text>the types of metrics that have been, or should be, established for the review and regulation of
			 over-the-counter drug products; and</text>
        </paragraph>
        <paragraph id="id252859a8dac54d718f51b0f8b2786dc1">
          <enum>(5)</enum>
          <text>timeliness, efficiency, and accountability in reviewing time and extent applications and safety and
			 effectiveness reviews for over-the-counter drug products.</text>
        </paragraph>
      </subsection>
      <subsection id="idBCA9580846B049469C50386651B23270">
        <enum>(c)</enum>
        <header>FDA report</header>
        <text>
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/ch:V/sch:I" entity-type="act">Subchapter I of chapter V of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref>, as amended by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Sunscreen Innovation Act/s:3" entity-type="act">section 3</cato:entity-ref>, is
			 further amended by adding at the end the following:</text>
        <quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id9F56000F60704ECD8FAFF9A4C043CF61" reported-display-style="italic" style="OLC">
          <section id="H5739649DEC01427FB6D42774104727C3">
            <enum>586G.</enum>
            <header>Report</header>
            <subsection id="HA514D42090334A9DA1AC802D8C1A869B">
              <enum>(a)</enum>
              <header>In general</header>
              <paragraph id="H636D1F1806D64576885D148A05A19D44">
                <enum>(1)</enum>
                <header>In general</header>
                <text>Not later than 18 months after the date of enactment of the <short-title>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                  </short-title>, and on the dates that are 2 and 4
			 years thereafter, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall issue a report to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="SSHR00" entity-type="committee">Committee on
			 Health, Education, Labor, and Pensions of the Senate</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="HIF00" entity-type="committee">Committee on
			 Energy and Commerce of the House of Representatives</cato:entity-ref> describing actions
			 taken under this subchapter.</text>
              </paragraph>
              <paragraph id="HBBC1936AE7DB4B9D9930095762F3EB11">
                <enum>(2)</enum>
                <header>Contents</header>
                <text>The reports under this subsection shall include—</text>
                <subparagraph id="H147675F88E3146B68AC745E2DC15C1D5">
                  <enum>(A)</enum>
                  <text>a review of the progress made in issuing GRASE determinations for pending requests, including the
			 number of pending requests—</text>
                  <clause id="H279266D86D2C4C9EABB81FB3FB5ACC5E">
                    <enum>(i)</enum>
                    <text>reviewed and the decision times for each request, measured from the date of the original request
			 for an eligibility determination submitted by the sponsor;</text>
                  </clause>
                  <clause id="H2387A186A9C54516B034E8593246343E">
                    <enum>(ii)</enum>
                    <text>resulting in a determination that the nonprescription sunscreen active ingredient or combination of
			 nonprescription sunscreen active ingredients is GRASE and is not
			 misbranded;</text>
                  </clause>
                  <clause id="H96A8BF3E336347FFAE7FD8BB72A84D9D">
                    <enum>(iii)</enum>
                    <text display-inline="yes-display-inline">resulting in a determination that the nonprescription sunscreen active ingredient or combination of
			 nonprescription sunscreen active ingredients is not GRASE and is
			 misbranded and the reasons for such determinations; and</text>
                  </clause>
                  <clause id="H2956133CDFBD43EBB25301AEBDDAFA3F">
                    <enum>(iv)</enum>
                    <text>for which a determination has not been made, and an explanation for the delay, a description of the
			 current status of each such request, and the length of time each such
			 request has been pending, measured from the date of original request for
			 an eligibility determination by the sponsor;</text>
                  </clause>
                </subparagraph>
                <subparagraph id="HA6B71B063D384B5FAA63841808BA93AB">
                  <enum>(B)</enum>
                  <text display-inline="yes-display-inline">a review of the progress made in issuing GRASE determinations for requests
			 not included in the reporting under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586G/ss:a/p:2/sp:A" entity-type="act">subparagraph (A)</cato:entity-ref>, including the number of such requests—</text>
                  <clause id="H2F05EA2527904AE9B3FD5AD21FD112B6">
                    <enum>(i)</enum>
                    <text>reviewed and the decision times for each request;</text>
                  </clause>
                  <clause display-inline="no-display-inline" id="HF17792991A844F9B847349B0AA80780E">
                    <enum>(ii)</enum>
                    <text display-inline="yes-display-inline">resulting in a determination that the nonprescription sunscreen active ingredient, combination of
			 nonprescription sunscreen active ingredients, or other ingredient is
			 GRASE and is not misbranded;</text>
                  </clause>
                  <clause id="H9D3BDFCE827444CF971D52EC33F1EC36">
                    <enum>(iii)</enum>
                    <text display-inline="yes-display-inline">resulting in a determination that the nonprescription sunscreen active ingredient, combination of
			 nonprescription sunscreen active ingredients, or other ingredient is not
			 GRASE and is
			 misbranded and the reasons for such determinations; and</text>
                  </clause>
                  <clause id="HCF8C0C451F5E423B9E3AAFE5F1CE2A86">
                    <enum>(iv)</enum>
                    <text display-inline="yes-display-inline">for which a determination has not been made, and an explanation for the delay, a description of the
			 current status of each such request, and the length of time each such
			 request has been pending, measured from the date of original request for
			 an eligibility determination by the sponsor;</text>
                  </clause>
                </subparagraph>
                <subparagraph id="H462F48445655460AB09BEAB62E0B84C3">
                  <enum>(C)</enum>
                  <text>an annual accounting (including information from years prior to the date of enactment of the <short-title>
                      <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" entity-type="act" value="Sunscreen Innovation Act">Sunscreen Innovation Act</cato:entity-ref>
                    </short-title> where such information is available) of the total number of requests submitted, pending, or
			 completed under this subchapter, including
			 whether such requests were the
			 subject of an advisory committee convened by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref>;</text>
                </subparagraph>
                <subparagraph id="id50B40E5742204D8C9A7D34B9E6F69339">
                  <enum>(D)</enum>
                  <text>a description of the staffing and resources relating to the costs associated with the review and
			 decisionmaking pertaining to requests under this subchapter;</text>
                </subparagraph>
                <subparagraph id="H44DD229E550041669149F33C67082A7F">
                  <enum>(E)</enum>
                  <text>a review of the progress made in meeting the deadlines with respect to processing requests under
			 this subchapter; and</text>
                </subparagraph>
                <subparagraph id="HB9BB8A44BE3346E693812BDA2E855CA0">
                  <enum>(F)</enum>
                  <text>to the extent the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> determines appropriate, recommendations for process improvements in the
			 handling of requests under this subchapter, including
			 the advisory committee
			 review process.</text>
                </subparagraph>
              </paragraph>
            </subsection>
            <subsection id="H6DF7145562C54B20B03DC6CC6A329EE1">
              <enum>(b)</enum>
              <header>Method</header>
              <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall publish the reports under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:586G/ss:a" entity-type="act">subsection (a)</cato:entity-ref> in the manner the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref>
			 determines to be the most effective for efficiently disseminating the
			 report, including publication of the report on the Internet website of the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Food and Drug Administration</cato:entity-ref>.</text>
            </subsection>
          </section>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
      </subsection>
    </section>
  </legis-body>
  <endorsement>
    <action-date>September 17 (legislative day, September 16), 2014</action-date>
    <action-desc>Reported with an amendment</action-desc>
  </endorsement>
</bill>
</doc>